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Summary 
  6 
Essential hypertension is associated with early vascular alterations, such as endothelial 
dysfunction, increased arterial stiffness and wave reflection, which are considered 
independent predictors of cardiovascular events. Since the clustering of risk factors, 
characterizing the metabolic syndrome, is associated with increased cardiovascular morbidity 
and mortality in hypertensive patients, the first aim of this study was to evaluate the effect of 
the presence of the metabolic syndrome on endothelial dysfunction, arterial stiffness and 
wave reflection in a population of untreated essential hypertensive patients. 
The most important non-pharmacological interventions in the prevention of cardiovascular 
disease are represented by physical activity and dietary changes. These interventions might 
have favorable effects on endothelial dysfunction, arterial stiffness and wave reflection. 
Therefore, the second aim of the study was to evaluate the effects of physical activity, dietary 
intake and supplementation of antioxidants on these vascular parameters in patients with 
essential hypertension. 
Cross sectional designs and a randomized, double blind, placebo controlled, crossover study 
design were used to address these research questions. Endothelium-dependent response was 
assessed as flow mediated dilation of the brachial artery. Arterial stiffness was assessed as 
central pulse wave velocity and augmentation index. The levels of habitual physical activity 
and dietary intake were assessed by validated questionnaires. Finally, plasma markers of 
oxidative stress and antioxidant status were measured. 
We demonstrated that the presence of the metabolic syndrome does not account for a further 
deterioration of vascular structural and functional parameters in our population of untreated 
hypertensive patients. Moreover, blood pressure was the most important component of the 
metabolic syndrome in defining conduit artery endothelial function and augmentation index in 
normotensive subjects, suggesting the primary role of high blood pressure in inducing early 
vascular alterations. 
Habitual physical activity was associated with a lower augmentation index in normotensive 
subjects and, to a lesser extent in untreated hypertensive patients. Thus, untreated essential 
hypertension seems to partially level out the beneficial impact of habitual physical activity on 
wave reflection. In a sample of healthy older individuals who performed regular and sustained 
endurance exercise training, we showed higher conduit artery endothelial function as 
compared to sedentary peers. This result was associated with preserved plasma antioxidant 
Summary 
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defenses, suggesting a protective role of regular intensive physical exercise on vascular 
oxidative stress. Although our cross sectional study showed that the levels of habitual intake 
of the antioxidant vitamins C and E in regular food were not associated with augmentation 
index and endothelial function in hypertensive patients and normotensive subjects, we 
demonstrated a beneficial effect of supplementation with combined vitamin C and E on 
endothelium-dependent vasodilation and arterial stiffness in a group of untreated hypertensive 
patients. This effect was associated with changes in plasma markers of oxidative stress. These 
results underline the necessity of adequate doses of combined antioxidants to exert beneficial 
effect on vascular parameters.  
Finally, results obtained in our cohort of hypertensive patients and control subjects suggest 
that the measurements of conduit artery endothelial function, central and peripheral arterial 
stiffness assess different entities of structure and function of the vascular tree. Therefore, in 
the risk assessment and in studies evaluating vascular function we recommend measuring 
both endothelial function and arterial stiffness. 
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Chapter 1 
INTRODUCTION 
  10 
Cardiovascular diseases (CVD) are the leading cause of mortality in the developed regions 1, 2 
of the world. In both developing and developed regions, high blood pressure is one of the 
major causes of disease burden 1, 2. The age- and sex-adjusted prevalence of hypertension is 
28% in the North American countries and 44% in the European countries at the 140/90 mm 
Hg threshold 3. Hypertension prevalence correlates with cardiovascular (CV) mortality and 
morbidity, in both male and female and in all age ranges 4. 
The last European guidelines on management of hypertension underline the importance of the 
evaluation of the total cardiovascular risk in hypertensive patients. Historically, therapeutic 
intervention thresholds for the treatment of cardiovascular risk factors such as blood pressure, 
blood cholesterol and blood sugar have been based on variably arbitrary cutpoints of the 
individual risk factors. Because risk factors cluster in individuals and there is a graded 
association between each risk factor and overall cardiovascular risk 5, 6, a stratification for 
total cardiovascular risk in hypertensive patients (ESH-ESC guidelines) is based on the 
presence of multiple risk factors, including abdominal obesity, in order to give specific 
attention to associated conditions such as for instance the metabolic syndrome 7. 
Figure 1 - Stratification of risk to quantify prognosis according to ESH-ESC guidelines 
 
The metabolic syndrome is a metabolic disorder consisting of a clustering of cardiovascular 
risk factors, including hypertension, abdominal obesity, dylipidemia (low HDL cholesterol), 
hypertriglyceridemia and hyperglycemia 8, carrying an increased risk for cardiovascular 
disease. In hypertensive patients the presence of the metabolic syndrome is associated with a 
poor cardiovascular outcome 9. The stratification of CV risk factors is furthermore based on 
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the presence of target organ damage (and associated clinical conditions) 10. The target organ 
damage includes left ventricular hypertrophy (LVH), increased intima-media thickening or 
plaques of carotid arteries, slight decrease in renal function and microalbuminuria. Finally, 
the actual ESH-ESC guidelines suggest that early vascular alterations, namely endothelial 
dysfunction and increased arterial stiffness and wave reflection might represent intermediate 
end-points for evaluation of the cardiovascular risk in hypertensive patients. 
Endothelial Function 
The endothelium is an autocrine-paracrine organ, which controls vascular tone and vascular 
structure. The endothelium produces multiple relaxing factors, with nitric oxide (NO) as the 
most important 11. NO is produced and released under the influence of endothelial agonists, 
such as acetylcholine and bradykinin, acting on specific endothelial receptors, and by 
mechanical forces, such as shear stress (figure 2). Healthy endothelium provides vascular tone 
and inhibits smooth muscle cell growth, blood plate aggregation and the adhesion of white 
blood cells 11 (figure 2). By definition endothelial dysfunction is a functional and reversible 
alteration of endothelial cells, resulting from impairment in NO availability 12 and is 
nowadays considered an early and major promoter for atherosclerosis and thrombosis.  
Figure 2 - Protective effect of the endothelium on vascular wall. NO: nitric oxide; •O2-: oxygen 
free radical; Ach: acetylcholine; BK: bradykinin 
NO
L-Arginine
M
ACh
Shear
Stress
•O2-
BK
Bk
M
Endothelium
RELAXATION
-
Proliferation 
Migration-
Aggregation-Adhesion -
NO-Synthase
Smooth muscle cells
 
  12 
In humans, endothelial function can be evaluated in different vascular districts, including the 
coronary and peripheral circulation. Intra-arterial infusion of endothelial agonists, such as 
acetylcholine, and local increase in shear stress has been used to study endothelium dependent 
vasodilation.  
However, the most widely used non-invasive technique to measure endothelial function is 
flow-mediated dilation (FMD) of the brachial artery. It assesses with high-resolution 
ultrasound the endothelium dependent change in artery diameter induced by reactive 
hyperemia and can be reported as the change in artery diameter after a period of induced 
ischemia compared to baseline artery diameter 13. 
Multiple studies already indicate that endothelial dysfunction is a characteristic of subjects 
with essential hypertension. However, endothelial dysfunction is not specific to essential 
hypertension, but rather results from cardiovascular risk factors, such as smoking, 
hypercholesterolemia, diabetes and aging 12. Furthermore, the metabolic syndrome has been 
associated with a high risk of cardiovascular disease in hypertensive patients 9 and it has been 
shown that the forearm response to acetylcholine is blunted in insulin resistant hypertensive 
patients in the presence of the metabolic syndrome as compared to hypertensive patients 
without the metabolic syndrome 14. However, in clinically healthy older men, the metabolic 
syndrome is not associated with impaired endothelial function, measured as flow mediated 
dilation of the brachial artery 15. 
CV risk factors are also accompanied by the presence of increased oxidative stress, defined as 
an excessive amount of oxidative substances, relative to endogenous antioxidant capacity 
which can inactivate NO 16, 17. Indeed, endothelium-dependent vasodilation to acetylcholine 
has shown to be significantly blunted in the forearm microcirculation of hypertensive patients 
16
 and this alteration is caused by increased vascular oxidative stress, which reduces NO 
availability 16. 
Endothelial dysfunction in hypertensive patients has been associated with target organ 
damage, such as increased intima-media thickening of the carotid arteries 18. Moreover, 
several clinical trials have shown that endothelial dysfunction, evaluated in both coronary and 
peripheral circulation, is associated with increased incidence of cardiovascular events in high-
risk patients 19. Moreover, FMD is inversely associated with cardiovascular risk in low risk 
populations 20. Thus, endothelial dysfunction is increasingly being recognized as an 
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independent predictor of future cardiovascular events and strategies aimed to improve 
endothelial function may be effective in reducing cardiovascular risk of hypertensive patients 
21
. 
Arterial Stiffness 
In the last decade, there has been a growing awareness that large arterial stiffness is an 
important marker in the development of cardiovascular disease. During a person’s life, as part 
of the ageing process or due to other cardiovascular risk factors, the aorta stiffens. The 
capacity of the large vessels to dampen the pulse waves after ventricular ejection diminishes 
and accordingly the forward pulse wave travels faster, reaching earlier the periphery arterial 
tree (figure 3).  
Figure 3 - Increase of aortic stiffness with aging 
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This results in increased and precocious reflected waves, which progressively reach the heart 
in late systole rather than in diastole. This process subsequently leads to higher systolic but 
lower diastolic blood pressure, therefore increasing the pulse pressure, decreasing diastolic 
perfusion and augmenting cardiac after load 22.  
The clinical assessment of arterial stiffness has been defined, described and measured in 
different ways 23. A current widely used technique to evaluate large artery function is non-
invasive pulse wave analysis and pulse wave velocity 24. The aortic pulse wave velocity or 
carotid- femoral pulse wave velocity (CFPWV) is known to be the more direct measure of 
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arterial stiffness and reflects central stiffness. CFPWV is the measurement of the speed of the 
pressure waves along the carotid and femoral arterial segments. CFPWV is calculated as the 
distance divided by the travel time of the wave between 2 sites of the pulse (figure 4). It is 
furthermore possible to measure peripheral pulse wave velocity (PPWV) by measuring at the 
radial and carotid artery sites. 
Pulse wave analysis (PWA) can be done to obtain data on the augmentation index (AIx) 
which is a representative surrogate of wave reflection, defined as augmented pressure due to 
wave reflection divided by the pulse pressure (figure 5). AIx is influenced by the amplitude 
and timing of forward and backward traveling pressure waves 25, 26. Finally, widened pulse 
pressure is an indirect indicator of increased arterial stiffness. 
Figure 4 - Measurement of Central (aortic) Pulse Wave Velocity 
 
Figure 5 - Measurement of Augmentation index and central pressure 
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Both the indexes of PWV and PWA are subject to different confounders. Age is one the most 
powerful predictors of cardiovascular disease and different studies have already demonstrated 
that age is associated with arterial stiffness 27, 28. Some authors suggest that this relation is 
linear, whereas others now imply that the relation changes with increasing age 27, 28. Female 
subjects in general have higher levels of both PWV and AIx, and this could be in part 
explained by the fact that women are on average shorter and have smaller and stiffer blood 
vessels resulting in an earlier return of the reflected wave 29. Heart rate has been associated 
with increased PWV and with lower reflected wave pressure, resulting in a lower AIx 27. 
Therefore in research on arterial stiffness, heart rate as well as gender has to be taken into 
consideration as a possible confounder especially in research topics such as physical activity. 
Hypertension has been associated with increased arterial stiffness and wave reflection 30 31. 
Sustained elevations in blood pressure can also lead to large artery stiffness and this in turn 
can accelerate the development and progression of systolic hypertension 31, 32. This 
pathological process contributes to hypertensive target organ damage 33, 34 with a 
subsequently increase in morbidity and mortality 30, 33. 
The metabolic syndrome is associated with an increased progression of aortic stiffness with 
age 35. Moreover, some studies have shown already that the metabolic syndrome is associated 
with an increased arterial stiffness in hypertensive patients 36-38, although this alteration is 
more evident for PWV as compared to AIx and in the female gender 39.  
Longitudinal epidemiological studies have demonstrated the independent predictive value of 
arterial stiffness and AIx for CV events. The largest amount of evidence has been given for 
aortic stiffness, measured through CFPWV. Aortic stiffness has independent predictive value 
for all-cause and CV mortalities, fatal and non-fatal coronary events, and fatal strokes in 
patients with uncomplicated essential hypertension 30, 40, type 2 diabetes 41, ESRD 42, 43, 
elderly subjects 44, 45 and the general population 46, 47. Thus, it is now well accepted that aortic 
stiffness is an intermediate endpoint for CV events. Central AIx and pulse pressure, measured 
either directly by carotid tonometry 48 or estimated using a transfer function from radial artery 
tonometry 49, 50 are both independent predictors of all-cause mortality in ESRD patients 48, 51 
and CV events in the hypertensive patients of the CAFE´ study 50. Therefore, strategies aimed 
at lowering arterial stiffness may be effective in reducing cardiovascular risk. 
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Non-pharmacological interventions 
In the battle for modifying cardiovascular risk factors and eventually in the prevention and 
reduction of CVD, the most important and studied non-pharmacological interventions are 
aimed at increasing physical activity and modifying dietary intake. A lifestyle combining 
regular daily physical activity and a healthy diet is recommended in maintaining body weight 
and should be the first approach in preventing, control and treatment of CVD. 
Physical activity 
In recent years there has been a focus on the benefits of physical exercise on cardiovascular 
disease. Long-term epidemiological studies have shown an unequivocal and robust relation of 
fitness, physical activity and exercise to reduced mortality overall and from cardiovascular 
causes and reduced cardiovascular risk 52, 53. Recent investigations have revealed great 
reductions in the risk of death from any cause and from cardiovascular disease. Being fit or 
active has been associated with a decrease is risk as great as 50% 54. The evidence of the 
effectiveness of regular physical activity in the primary and secondary prevention of CVD, 
but also other chronic diseases such as diabetes, hypertension, and obesity, is irrefutable. 
Therefore sedentary behavior is considered a CV risk factor, considering that the prevalence 
of physical inactivity is higher than that of all other modifiable risk factors. 
Physical activity and hypertension 
It is well known that life-style habits and modifications are important in the prevention and 
treatment of hypertension and it has been shown that regular physical exercise exerts positive 
effects on blood pressure. In the prevention of hypertension, longitudinal studies have 
indicated that higher levels of physical activity or fitness are associated with a lower 
incidence of hypertension 55. A meta-analysis of 54 randomized trials showed that aerobic 
exercise is associated with an overall reduction in mean blood pressure, independent of body 
weight and race 56. In addition, a second meta-analysis showed that dynamic aerobic training 
reduces blood pressure, with a more pronounced effect in absolute values in hypertensive 
patients than in normotensive subjects 57. Finally, the blood pressure reductions through 
exercise result in a decrease in CHD, stroke and total mortality 56. The findings of a follow-up 
study of 16 years showed that physical activity in individuals with moderate hypertension can 
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in part counteract on the adverse effects of high blood pressure on the cardiovascular system 
58
.  
Since hypertension has been associated with early vascular alterations, such as endothelial 
dysfunction and arterial stiffness, more recently attention has been focused on vascular 
function and structure in preventing cardiovascular disease.  
Physical activity and endothelial function 
Studies have already suggested that physical exercise shows associations with endothelial 
(dys) function. Different intervention studies reveal a correction of endothelial dysfunction 
with physical training in patients with chronic heart failure 59, 60 and coronary artery disease 61, 
62
. Similar studies have shown that aerobic exercise training improved conduit and resistance 
vessel endothelial vasodilator function in middle-aged patients with type 2 63 and type-1 
diabetes patients 64 and patients with essential hypertension 65.  
Studies in healthy subjects show an improvement in endothelial function (FMD) in young 
healthy subjects after aerobic and anaerobic exercise training 66. In addition, regular aerobic 
exercise can prevent and even restore the age-associated loss in endothelium dependent 
vasodilation in previously sedentary middle aged and older men 67. Regular physical activity 
in elderly athletes can at least in part prevent the age-induced endothelial dysfunction 68. 
However no data is available on the effect of different levels of regular habitual physical 
activity on endothelial function. 
The mechanisms through which physical exercise can improve endothelial function are not 
fully clarified. A role for shear stress, which is a physiologic stimulus for NO release, has 
been hypothesized, stimulating NO production by an increased expression of nitric oxide 
synthase. Furthermore, physical activity might ameliorate endothelial function by 
downregulating sympathetic nervous system and decreasing insulin resistance and glucose 
intolerance 69, 70. However the most important mechanism might be the modulation of 
oxidative stress, reducing the production of ROS and increasing antioxidant defenses 71-73. 
The latter mechanisms are associated with preserved NO availability.   
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Physical activity and arterial stiffness 
Regarding arterial stiffness, available evidence indicates that physically active adults show 
attenuation in the age-related increase in arterial stiffness in comparison with their sedentary 
peers 74, 75. Furthermore, an observational study conducted in a cohort of men and women free 
of cardiovascular disease, demonstrated an inverse association between habitual physical 
activity and arterial stiffness 76. 
Studies have been conducted to evaluate the effect of high intensity exercise on arterial 
stiffness. A cross-sectional study showed that older men who performed endurance exercise 
had lower levels of aortic pulse wave velocity and augmentation index than their sedentary 
peers 77. A lower aortic pulse wave velocity was also demonstrated in individuals performing 
habitual endurance exercise as compared to recreationally active individuals 74 
Intervention studies aimed to improve arterial stiffness showed that a moderate intensity and 
walking type of physical activity increased carotid arterial compliance in previously 
sedentary, but healthy middle-aged and older men 78, 79. The main causes of arterial stiffening 
with age are a decrease in elastin and the proliferation of collagen fibers in the vascular wall, 
together with vasoconstrictor tone exerted by its smooth muscle cells 80. As mentioned before, 
physical activity seems to attenuate the age-related changes of the arterial wall. Explanations 
for the beneficial effect of physical activity on arterial stiffness could be a decrease in 
sympathetic tone and a possibly improvement in endothelial function. However, these 
mechanisms have not been fully clarified or studied yet. 
In summary, persons who are physically active maintain a more favorable cardiovascular risk 
profile. Regular physical activity not only lowers blood pressure levels but also attenuates the 
age- related increase in arterial stiffness, which is increasingly being recognized as 
independent cardiovascular risk factor. Until the present time however no data is present on 
the relation between physical activity status and augmentation index, a marker of wave 
reflection in the arterial tree, especially in patients with essential hypertension. Furthermore, it 
is not known if physical activity exerts different effects on the vascular system in healthy 
subjects or in patients with hypertension. 
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The role of antioxidants 
Literature indicates that cardiovascular risk factors such as aging and hypertension are 
accompanied by the presence of endothelial dysfunction and oxidative stress. Oxidative 
stress, defined as an excessive amount of oxidative substances, relative to endogenous 
antioxidant capacity, indeed has shown to be increased in conditions such as hypertension, 
resulting in a reduced NO-availability in these subjects 16, 17. It has been suggested that 
antioxidants provide vascular defense against oxidative stress by reducing free radicals and 
protecting NO from inactivation, therefore exerting its’ beneficial effects on vascular function 
and structure.  
In essential hypertension the breakdown of NO, through oxidative stress, results in an 
ongoing pathogenesis of endothelial dysfunction and atherosclerosis. Lately, it has been 
suggested that nitric oxide may play a role in regulating arterial stiffness. Studies have shown 
that substances associated with increase in NO production, including glyceryl trinitrate 
(GTN), reduce arterial stiffness and wave augmentation, whereas inhibitors of NO, such as L-
NMMA, increase indexes of arterial stiffness 81. As mentioned before, physical exercise e.g. 
shear stress can counteract on this pathogenesis by stimulating the release of nitric oxide. 
Another important mechanism through which exercise can improve vascular function is the 
antioxidant defense capacity. The antioxidant defense capacity is of vital importance in the 
protection against oxidative stress. Studies indicate that regular physical activity can preserve 
and upregulate the antioxidant defense capacity. It was shown that physically active older 
adults might have an improved intracellular antioxidant defense mechanism 71, whereas 
animal studies show that training induces gene expression of muscle anti-oxidant enzymes 
such as glutathione peroxidase and superoxide dismutase 72. Furthermore, regular physical 
activity was closely related with an increased overall oxidant capacity in healthy subjects 73. 
On the contrary another study pointed out that the level of habitual physical activity and 
aerobic capacity have no major influence on the resting balance between radical generation 
and blood-oxidant potential in healthy older man 82. On the whole, it seems that physical 
activity increases antioxidant capacity, an increase that is becoming more pronounced with 
aging. However until now it is not fully clear what the relationship is between physical 
activity, antioxidant capacity and vascular function. 
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The studies on the effect of physical exercise on cardiovascular risk factors and endothelial 
function are numerous. It is also indicated that the effect of physical exercise can be 
significantly magnified by other lifestyle changes such as changes in dietary composition and 
weight loss. The Diet, Exercise and Weight Loss Intervention Trial (DEW-IT)83 showed that a 
lifestyle intervention can substantially lower blood pressure and improve blood pressure 
control. An intervention study using an unrestricted consumption of a low-fat, high-fiber diet 
and daily exercise showed a dramatic improvement in both, blood pressure, oxidative stress 
and NO availability in obese men 84. 
Studies have been done on the effect of antioxidant vitamins, in regular foods or as food 
supplements and the risk of cardiovascular disease. In some observational studies a higher 
intake of antioxidant vitamins or higher plasma levels of antioxidants was associated with 
lower risk of myocardial infarction and/or stroke 85. These effects were demonstrated for 
carotene, ascorbic acid and tocopherol. However, another study, which measured dietary 
intake and plasma levels of antioxidant vitamins, provided limited support for the hypothesis 
that increased intake of antioxidant vitamins decreases the risk of atherosclerosis, measured as 
carotid artery intima media thickness in a randomly selected community population 86. In this 
study no benefit was demonstrated for supplemental antioxidant vitamin use. 
It can be hypothesized that high dietary intake of vitamin supplementation or experimental 
oral supplementation with antioxidants can have beneficial effects on cardiovascular disease 
especially in patients with essential hypertension. However, there is no data available on the 
association of regular dietary intake of antioxidant vitamins and endothelial function and 
arterial stiffness. Different studies have already been conducted on the possible effects of 
Vitamin E or Vitamin C supplementation on cardiovascular disease. Until the present time 
though, no data exists on the effect of a combined treatment with Vitamin C and E on arterial 
stiffness and endothelial function in patients with hypertension. 
Aims of the study 
The aim of the studies is to investigate the role of the metabolic syndrome in hypertensive 
patients and to evaluate the effects of physical activity, dietary intake and antioxidants on 
vascular function and structure, especially in hypertensive patients.  In order to address this 
aim the following research questions were developed: 
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• To determine the effect of the presence of the metabolic syndrome in hypertensive 
patients on arterial stiffness and endothelial function. 
• To determine the relation between habitual physical activity and augmentation index in 
hypertensive patients. 
• To evaluate the relation between physical activity, antioxidant capacity and endothelial 
function in healthy subjects  
• To evaluate the associations between dietary intake and vascular function and vascular 
structure in normotensive subject and hypertensive patients.  
• To test the effect of supplementation with Vitamin C and E on arterial stiffness and 
endothelial function in hypertensive patients.  
• To determine the relationship between measurement of endothelial function (FMD) and 
measurements of arterial stiffness (PWA and PWV). 
  22 
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Chapter 2 
NO DIFFERENCES IN AUGMENTATION INDEX OR 
ENDOTHELIAL FUNCTION IN ESSENTIAL 
HYPERTENSIVE PATIENTS WITH OR WITHOUT 
THE METABOLIC SYNDROME 
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Abstract 
Background. Essential hypertension is characterized by endothelial dysfunction and arterial 
stiffness. The metabolic syndrome has been associated with a high risk of cardiovascular 
disease in hypertensive patients. We evaluated augmentation index, an index of wave 
reflection and endothelial function in untreated essential hypertensive patients with or without 
the metabolic syndrome in comparison with normotensive controls. 
Methods. Augmentation index was determined with radial applanation tonometry in 232 
untreated hypertensive patients and 241 normotensive subjects. Endothelium-dependent 
response was assessed as flow mediated dilation (FMD) of the brachial artery. The metabolic 
syndrome (MS) was defined according to the latest National Cholesterol Education Program 
Adult Treatment panel III (ATP III). 
Results. No significant differences were found for AIx or FMD between hypertensive 
patients with or without the MS. In the normotensive control group, no difference was found 
for AIx or FMD between subjects with or without the metabolic syndrome. From zero to 3 or 
more risk factors, in both hypertensive and normotensive subjects, no significant trend was 
seen for AIx or FMD. Multiple regression analysis showed that age, diastolic blood pressure 
(DBP) and female gender were the significant predictors of AIx and age, DBP and brachial 
artery diameter for FMD. 
Conclusions. In our population of untreated hypertensive patients and normotensive controls, 
the presence of the metabolic syndrome does not account for a further deterioration of 
vascular structural and functional parameters.  These results support the hypothesis that blood 
pressure is the most important component of the metabolic syndrome in defining conduit 
artery endothelial function and AIx in these subjects. 
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Introduction 
The metabolic syndrome is a metabolic disorder consisting of a clustering of cardiovascular 
risk factors 1, 2. It is known that the metabolic syndrome carries an increased risk for 
cardiovascular disease1-3 Furthermore, the metabolic syndrome has been associated with a 
high risk of cardiovascular disease in hypertensive patients 4.  
It is known that essential hypertensive patients are characterized by premature alterations in 
vascular structure and function which can lead to cardiovascular complications. Moreover, 
these vascular changes observed in hypertension are generally considered to be an accelerated 
form of the changes seen with aging. Indeed, hypertension is associated with increased 
arterial stiffness 5-7 and endothelial dysfunction 8, 9 and these vascular alterations are 
increasingly being recognized as powerful predictors of cardiovascular disease morbidity and 
mortality 6, 7, 10, 11.  
It has been hypothesized that hypertensive patients in presence of the metabolic syndrome 
would also show both earlier and more severe structural and functional alterations of the 
vascular wall. For this reason research has been focused on the impact of the metabolic 
syndrome on these vascular parameters. Recent studies suggest that the metabolic syndrome 
is associated with an increased arterial stiffness in hypertensive patients 12-14. Regarding 
endothelial function, is has been demonstrated that the response to acethylcholine in the 
forearm microcirculation was blunted in insulin resistant hypertensive patients in the presence 
of the metabolic syndrome as compared to hypertensive patients without the metabolic 
syndrome 15. However, in clinically healthy older men, the metabolic syndrome was not 
associated with impaired endothelial function, measured as flow mediated dilation of the 
brachial artery 16. 
Until the present time no data is available on the effect of the metabolic syndrome on 
augmentation index and conduit artery endothelial function in essential hypertensive patients. 
Therefore, the aim of this study was to evaluate augmentation index, an index of peripheral 
wave reflection, and endothelial function measured as flow mediated dilation in a population 
of untreated essential hypertensive patients with or without the metabolic syndrome in 
comparison with normotensive controls. 
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Methods 
Study population 
In this cross-sectional study, 232 (74 females) hypertensive patients (HT) between 20 and 70 
years of age were recruited for the study from February 2004 to December 2005. Patients with 
essential hypertension were recruited from the newly diagnosed cases in our outpatient clinic 
and were enrolled if sitting clinic arterial blood pressure (after 10 minutes of rest) was 
consistently found to be greater than 140/90 mmHg, confirmed in two separate occasions 
within one month according to European guidelines 17. Patients had never been treated 
(n=162) or had a history of recent or discontinuous treatment (n=70), with a pharmacological 
washout for at least 3 weeks before entering the study. Subjects with medical history of 
cardiovascular events, cardiovascular diseases or other diseases requiring medical treatment, 
were excluded for the study. To serve as control, 241 normotensive subjects (NT) (105 
females) were added. Subjects were defined as normal according to the absence of familial 
history of essential hypertension and blood pressure values below 140/90 mmHg. To avoid 
the influence of other overt disease, diabetic patients were excluded for the study. 
Body weight, height and waist circumference (WC) were measured in all subjects, body mass 
index (BMI was) calculated as weight/height2. Blood samples were collected following an 
overnight fast to measure lipid and glucose profile. Information on current smoking status 
(smoker/non smoker) was also collected. Physical activity levels were assessed and controlled 
with a modified Baecke questionnaire18. Written informed consent was obtained from each 
patient. 
The metabolic syndrome (MS) was defined according to the latest National Cholesterol 
Education Program Adult Treatment panel III (ATP III) 3. Subjects were considered to have 
the metabolic syndrome if they had at least three of the of the five following characteristics: 
1) serum triglyceride levels ≥ 1.69 mmol/L (150 mg/dL); 2) serum HDL cholesterol < 1.04 
mmol/L (40 mg/dL) in men and <1.30 mmol/L (50 mg/dL)  in women; 3) fasting plasma 
glucose ≥ 5.55 mmol/L (100 mg/dL); 4) waist circumference > 102 cm in men and > 88 cm in 
women; 5) blood pressure (BP) ≥ 130/85 mmHg. Hypertensive patients had to fulfill 2 or 
more of the first 4 criteria. 
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The whole study group was furthermore divided in four groups on basis of the different 
components of the metabolic syndrome 1) no risk factor; 2) 1 risk factor; 3) two risk factors 
and 4) 3 or more risk factors.  
Vascular function 
Blood pressure (BP) was measured three times at 3 minutes interval by automatic device at 
the dominant arm (OMRON-950 CP) and was calculated as the mean value of the last two 
measurements. Radial tonometry was performed by one trained operator (Y.P.). After an 
overnight fast, measurements were performed with the subjects in supine position in a quiet, 
air-conditioned room (22-24°C). A hand held probe was placed on the radial artery from the 
wrist of the dominant arm and 10-15 subsequent images were recorded. Pulse Wave Analysis 
(PWA) (SphygmoCor, AtCor Medical, Sydney, Australia) was used to transform the radial 
pressure waveform into the aortic pressure waveform by using a validated transfer function 7, 
19
. Three successive measurements were recorded. Augmented pressure (AP) was calculated 
as the difference between the second systolic peak and the first systolic peak and 
augmentation index (AIx) was calculated as the ratio between AP and pulse pressure (PP). 
Since AIx in this study correlated with heart rate, values were normalized at a heart rate of 75 
beats/min. An intra-observer reproducibility study in our lab showed a coefficient of variation 
of 14% for AIx. 
Endothelium-dependent response was assessed as dilation of the brachial artery to increased 
flow (flow mediated dilation, FMD), as previously described 20, 21. Briefly, a B-mode scan of 
the right brachial artery was obtained in longitudinal section between 5 cm and 10 cm above 
the elbow using a 7.5 MHz linear array transducer, held by a stereotactic clamp to ensure a 
constant image. B-mode images were triggered to the ECG signal to obtain only end-diastolic 
frames. Arterial flow velocity was obtained by pulsed Doppler signal at 70° to the vessel with 
the range gate (1.5 mm) in the center of the artery. A cuff was placed around the forearm just 
below the elbow and was inflated for five minutes at 250 mmHg and then deflated to induce 
reactive hyperemia.  
Endothelium-independent dilation was obtained by administration of a low dose (25 µg) of 
sublingual glyceril trinitrate (GTN). Brachial artery diameter (BAD) measurements were 
performed after studying the acquired frames by the computerized edge detection system 22. 
Baseline vessel size was considered as the mean of measures obtained during the first minute. 
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FMD and response to GTN were calculated as the maximal percent increase in diameter 
above baseline. Doppler flow velocity was measured at baseline and within 15 seconds after 
cuff release. Volume blood flow was calculated by multiplying Doppler flow velocity 
(corrected for the angle) by heart rate and vessel cross-sectional area (pir2). Reactive 
hyperemia (RH) was calculated as the maximum percent increase in flow after cuff release as 
compared to baseline flow.  
Statistical analysis. 
Data are expressed as means ± SD. Because of skewed distribution of triglycerides, this 
variable was logarithmically transformed, and is expressed as median and interquartile range. 
Characteristics of subjects with or without the metabolic syndrome were compared using 
Student’s t-tests or non-parametric test if necessary. All further analysis were adjusted for 
age, gender, smoking status and physical activity status. Differences in outcome parameters, 
according to the presence and absence of the MS were tested with analysis of covariance in 
HT and NT groups separately. Separate analysis was made for gender subgroups, divided for 
hypertension status and the presence or absence of the MS. The effects of the single 
dichotomized components of the MS according to the ATPIII criteria 3 on the vascular 
parameters were tested by analysis of covariance. Simple and multiple regression analyses 
were used to examine univariate and independent correlates of the vascular parameters. 
Comparison between groups with different risk factors (0, 1, 2, 3 or more) was made by 
general linear model. Differences were considered statistically significant when p < 0.05. All 
statistical procedures were performed using the Statview program (Abacus Concepts, Inc., 
SAS Institute, Cary, NC). 
Results 
The clinical characteristics of the study population are shown in table 1. Within the group of 
HT patients, 30% (69/232) was defined as having the metabolic syndrome (HT/MS+). Within 
the NT group 24% (59/241) met the criteria of the metabolic syndrome (NT/MS+).  
In HT and NT groups separately, significant differences were shown for BMI, WC, 
triglycerides and plasma glucose, which were all significant higher in patients or subjects with 
the metabolic syndrome, whereas HDL resulted lower in patients with metabolic syndrome. 
No significant differences were found in age, smoking, systolic (SBP) and diastolic blood 
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pressure (DBP) between individuals with or without the MS in the HT group or in the NT 
group. Within the HT group, brachial artery diameter was significantly higher in HT/MS+ as 
compared to hypertensive patients without the metabolic syndrome (HT/MS-), whereas the 
percentage of female gender resulted lower in HT/MS+.  
Table 1 - Clinical characteristics of study population 
 HT/MS+ 
(n=69) 
HT/MS- 
(n=163) 
NT/MS+ 
(n=59) 
NT/MS- 
(n=182) 
Age (years) 
BMI (kg/m2) 
Waist circumf. (cm) 
Height (cm) 
Gender (M/F%) 
Smoking (%) 
SBP (mmHg) 
DBP (mmHg) 
Total cholesterol (mg/dl) 
HDL cholesterol (mg/dl) 
Triglycerides (mg/dl) 
Plasma glucose (mg/dl) 
BA diameter (mm) 
Level physical activity 
48.9 ± 10.4 
29.0 ± 3.3† 
102.6 ± 8.6† 
172.2 ± 9.9 
79/21† 
21 
156.8 ± 15.1 
95.1 ± 7.5 
208.9 ± 41.5 
41.9 ± 11.5† 
186.2 (159-217)† 
103.4 ± 23.0† 
4.91 ± 0.8† 
7.0 ± 1.5 
48.2 ± 8.8 
25.5 ± 8.8 
90.8 ± 9.8 
171.7 ± 10.1 
63/37 
17 
155.2 ± 14.6 
95.7 ± 7.2 
204.9 ± 37.6 
54.5 ± 13.3 
108.5 (73-131) 
90.5 ± 9.6 
4.40 ± 0.9 
7.2 ± 1.3 
49.5 ± 10.4 
29.9 ± 3.7* 
105.6 ± 8.9* 
169.3 ± 9.8 
53/47 
20 
129.5 ± 7.9 
79.7 ± 6.2 
227.1 ± 48.3* 
44.7 ± 7.8* 
182.8 (159-256)* 
111.9 ± 17.3* 
4.05 ± 0.9 
7.0 ± 1.2 
47.6 ± 8.8 
26.5 ± 3.4 
95.3 ± 9.5 
170.3 ± 9.9 
56/44 
17 
128.5 ± 9.6 
79.4 ± 6.3 
202.2 ± 35.0 
54.3 ± 13.0 
115.4 (65-137) 
92.8 ± 10.5 
4.18 ± 0.8 
7.2 ± 1.5 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
HDL= high-density lipoprotein; LDL= low-density lipoprotein; 
BA diameter= brachial artery diameter. * P<0.05 NT/MS- vs. NT/MS+ and † HT/MS- vs. HT/MS+. 
In the whole group, AIx resulted significantly higher in HT as compared to NT (25.5±9.8 vs. 
18.4±11.2; p<0.0001), whereas FMD resulted significantly lower (5.0±2.5 vs 6.0±2.7; 
p<0.001). No significant difference was found in the response to GTN (8.0±3.5 vs 7.9±3.4; 
p=ns). No significant differences between HT/MS+ or HT/MS- were found for AIx. 
Furthermore, in the normotensive control group there was no significant difference between 
NT/MS+ or normotensive subjects without the metabolic syndrome (NT/MS-) (figure 1). A 
significant higher AIx was observed in HT/MS- compared with NT/MS-, as well as a 
significant higher AIx in HT/MS+ as compared to NT/MS+. Finally, AIx was significantly 
higher in HT/MS- as compared to NT/MS+ (figure 1). 
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Figure 1 - Differences in augmentation index (AIx) and flow mediated dilation (FMD) in 
hypertensive patients and normotensive subjects with (MS+, black white bars) or without (MS-, 
white bars) the metabolic syndrome. Data are shown as mean± standard error. * Denotes a 
significant (p<0.05) difference HT MS- vs. NT MS- (p<0.05); † HT MS+ vs. NT MS+; ‡ HT MS- 
vs. NT MS+. 
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In the separate analysis for gender, a significant lower AIx and significant higher values of 
time to reflection (Tr) and BAD were found in hypertensive female subjects with the MS as 
compared to female hypertensive subjects in absence of the MS (Table 2). In the 
normotensive female group, Tr and BAD resulted significantly higher in subjects with the MS 
as compared to subjects without the MS. In the male subgroup no significant differences were 
found for any of the vascular parameters (Table 2). All analysis were repeated for central 
SBP, DBP and pulse pressure (PP), but no significant differences were found for any of these 
parameters (data not shown). 
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Table 2 - Age-adjusted values of vascular parameters in male and female hypertensive patients 
and normotensive subjects according to the absence (MS-) or presence (MS+) of the metabolic 
syndrome. * p < 0.05 MS- versus MS+. Data are shown as mean ± SE. 
 Hypertensive patients 
 Males Females 
Parameters MS+ (n=55) MS – (n=103) MS +  (n=14) MS – (n=60) 
AIx 22.7±0.9 22.3±0.7 26.9±1.8* 32.7±0.9 
Tr (ms) 143±3 144±2 139±4* 133±2 
cSBP (mmHg) 143±2 145±2 148±4 147±2 
cPP (mmHg) 48±1 49±1 54±3 53±1 
BAD (mm) 4.9±0.1 4.7±0.1 4.4±0.2* 3.9±0.1 
FMD (%) 4.9±0.3 4.9±0.3 5.6±0.8 5.7±0.4 
RH (%) 572±41 632±35 653±69 586±45 
GTN (%) 7.7±0.5 7.6±0.3 7.5±0.9 8.0±0.4 
 Normotensive subjects 
 Males Females 
Parameters MS+ (n=36) MS – (n=100) MS +  (n=23) MS – (n=82) 
AIx 15.4±1.5 15.1±0.9 23.1±1.8 25.3±1.0 
Tr (ms) 154±4 150±2 146±6 140±3 
cSBP (mmHg) 127±2 124±1 121±3 123±1 
cPP (mmHg) 42±1 41±1 42±2 40±1 
BAD (mm) 4.9±0.1 4.7±0.1 4.4±0.2* 3.9±0.1 
FMD (%) 5.7±0.4 5.8±0.3 6.4±0.8 6.7±0.5 
RH (%) 528±37 569±32 487±69 592±45 
GTN (%) 8.6±0.5 8.5±0.3 8.4±0.8 8.8±0.6 
AIx: augmentation index; Tr: time to reflection; cSBP: central systolic blood pressure; 
cPP: central pulse pressure; BAD; brachial artery diameter; FMD: flow mediated dilation; 
RH: reactive hyperemia; GTN: response to sublingual nitroglycerin 
Regarding FMD, no significant difference was found between HT/MS+ and HT/MS-, nor 
between NT/MS+ and NT/MS-. HT/MS- showed a significantly lower FMD as compared to 
NT/MS- and HT/MS+ showed a significant lower FMD as compared to NT/MS+ (figure 1). 
Furthermore, no significant differences were found in response to GTN between the groups. 
Dividing for gender, hypertension status and the presence or absence of the MS, no significant 
differences in FMD or response to GTN were seen in male and female subjects (Table 2). 
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In the analysis evaluating the effect of the dichotomized single components of the MS, no 
significant differences were seen for AIx or FMD in the hypertensive group (figure 2 and 3). 
In the normotensive group, FMD was not influenced by any of the dichotomized variables, 
while AIx was higher in subjects with higher BP values and lower in subjects with higher WC 
(figure 2 and 3). 
Figure 2 - The behavior of augmentation index (AIx) and flow mediated dilation (FMD) 
according to the presence of 0, 1, 2, 3 or more components of the metabolic syndrome in 
hypertensive patients (circle) and normotensive subjects (triangle). 
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In the hypertensive group, simple regression analysis showed that AIx correlated (p<0.05 or 
less) with age (r=0.37), SBP (r=0.20), DBP (r=0.17), total cholesterol (r=0.20) and inversely 
with height (r=-0.43), BMI (r=-0.17) and WC (r=-0.17). Finally, FMD correlated negatively 
(p<0.05 or less) with BAD (r=-0.43), age (r=-0.31), SBP (r=-0.16) and BMI (r=-0.13). The 
multiple regression analysis showed that the predictors of AIx were represented by age, DBP 
and female gender (R2=0.56). For FMD, the significant predictors were age and BAD 
(R2=0.23). When the metabolic syndrome was added as dummy variable in the multiple 
regression models, the results did not change. 
Chapter 2 
 41 
Figure 3 - Differences in augmentation index (AIx) according to the presence (black bar) or 
absence (white bar) of the single components of the metabolic syndrome in hypertensive patients 
and normotensive subjects.  Mean (standard error) 
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Univariate regression analysis in the normotensive group showed that age (r=0.52), DBP 
(r=0.28) and total cholesterol (r=0.18) were positively associated with AIx, whereas height 
was negatively associated (r=-0.48). FMD showed significant inverse associations with age 
(r=-0.26), BAD (r=-0.43), BMI (r=-0.23), WC (r=-0.27) and DBP (r=-0.16). Multiple 
regression analysis showed that age, DBP and female gender were the significant predictors 
of AIx (R2 =0.53). For FMD the significant predictors were BAD, age and DBP (R2=0.38). 
Adding the metabolic syndrome as a dummy variable in the models did not change the results.  
In the overall population, using the general linear model, there was no significant increase in 
AIx, from zero to 3 or more risk factors in both hypertensive patients and normotensive 
subjects (fig. 4). For FMD, in the normotensive group, a non significant decrease was seen 
from 0 to 3 or more risk factors, whereas in the hypertensive patients no decrease was evident 
(fig 4.). Finally, no trend was seen for GTN in both groups. 
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Figure 4 - Differences in flow mediated dilation (FMD) according to the presence (black bar) or 
absence (white bar) of the single components of the metabolic syndrome in hypertensive patients 
and normotensive subjects.  Mean (standard error) 
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Discussion 
The present study demonstrates that in our population, the metabolic syndrome does not 
account for a further deterioration of vascular structure and function. We showed that AIx, 
which represents an integrated index of peripheral wave reflection, and FMD, a measure of 
large conduit artery endothelial function, are not influenced by the presence of the metabolic 
syndrome both in untreated essential hypertensive patients and in normotensive controls. 
Hypertensive patients showed a higher AIx and reduced endothelium dependent dilation as 
compared with normotensive subjects, irrespective of the presence of the metabolic 
syndrome. Our data confirm already existing data, showing that hypertension is associated 
with a reduced endothelium dependent vasodilation 23, and increased arterial stiffness 6 and 
wave reflection 5. Moreover, in the hypertensive patient, AIx was not influenced by any of the 
single components of the metabolic syndrome, whereas in the normotensive controls only 
blood pressure levels influenced AIx. 
Different studies suggested that the metabolic syndrome is associated with increased arterial 
stiffness in hypertensive patients. One study showed that central PWV was independently 
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associated with the metabolic syndrome in untreated hypertensive patients 12. Increased aortic 
stiffness, measured as carotid femoral pulse wave velocity, was shown in untreated 
hypertensive patients with the metabolic syndrome, but this association was largely dependent 
of age, systolic blood pressure and albumin excretion rate 13. Another study showed that the 
metabolic syndrome was adversely associated with both carotid intima-media thickness and 
arterial stiffness measured as carotid femoral pulse wave velocity 14. However in the latter 
study, blood pressure levels were shown to be the most important component of the metabolic 
syndrome in defining artery structure and function.  
The above mentioned studies indicate that the metabolic syndrome can increase central 
arterial stiffness, measured as carotid-femoral PWV. The lack of effect of the metabolic 
syndrome on AIx, indicates a dissociation in the influence of the metabolic syndrome on the 
various districts or functions of the arterial tree. Interestingly, our results are in line with data 
obtained in a cohort of treated hypertensive patients, in which AIx was similar in patients with 
or without the metabolic syndrome 24. Accordingly, one study showed that patients with type-
2 diabetes did not have a greater aortic pressure augmentation from peripheral wave reflection 
when compared with subjects without diabetes 25.  Interestingly, in our study population an 
even lower AIx, together with an increased time to refection, was found in hypertensive 
female subjects in presence of the metabolic syndrome as compared to hypertensive females 
without the metabolic syndrome, confirming a blunted arterial wave reflection in female 
subjects in presence of the metabolic syndrome 24. In line, it has been hypothesized that 
adipose tissue at small conduit artery site, can slow wave reflection. This hypothesis was 
supported by the finding that pressure exerted externally on the hand or leg can reduce wave 
reflection, resulting in decreased arterial transmural pressure, leaving the peripheral arteries 
apparently less stiff 26.  
Finally, brachial artery diameter was significantly higher in the female subjects with the 
metabolic syndrome as compared to female subjects without the metabolic syndrome. Since 
in the multiple regression analysis brachial artery diameter resulted as significant negative 
predictor of AIx, the before mentioned differences can in part account for our results 
regarding AIx.  
Regarding endothelial function, we did not find any significant difference in endothelial 
function between subjects with or without the metabolic syndrome. Our results are in line 
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with a study performed in otherwise clinically healthy older men, which showed that the 
metabolic syndrome was not associated with impaired endothelial function, measured as flow 
mediated dilation of the brachial artery 16. On the other hand is has been demonstrated that the 
forearm response to acetylcholine in the forearm microcirculation was blunted in insulin 
resistant hypertensive patients in the presence of the metabolic syndrome as compared to 
hypertensive patients without the metabolic syndrome 15.  
Importantly, in our study we used the National Cholesterol Education Program (NCEP) Adult 
Treatment Panel III (ATPIII)3 guidelines to define the presence of the metabolic syndrome, 
which does not include any measurement of insulin resistance. We can only speculate if the 
results would be different adding a measurement of insulin resistance. 
Moreover, the lack of influence of the metabolic syndrome on the vascular parameters could 
be explained by the presence of overt disease such as untreated hypertension. In our 
population of untreated hypertensive patients, the incremental risk attributable, for example, 
to raised triglycerides or low HDL-cholesterol, is likely to be overwhelmed by the presence of 
hypertension. Moreover, the study population was screened and recruited on basis of blood 
pressure levels. Therefore the population resulted heterogeneous regarding the different 
components of the metabolic syndrome. Furthermore, the hypertensive patients were not 
extremely overweight and did not show overt dyslipidemia.  
The results in the normotensive control group were unexpected. The metabolic syndrome was 
not associated with higher AIx or lower FMD. However, we showed that within the 
normotensive control group, higher blood pressure levels were associated with a higher AIx, 
confirming the major effect of blood pressure levels on this vascular parameter. Accordingly, 
it is important to underline that AIx was higher in HT patients without the metabolic 
syndrome as compared to NT patients with the metabolic syndrome. However, since in our 
control group only 24 % was defined as having the metabolic syndrome, we are cautious in 
drawing strong conclusions on the effect of the metabolic syndrome in this subgroup. 
Increasing age was found to be positively associated with AIx in both hypertensive patients 
and normotensive subjects, confirming previous observations of a positive association 
between increasing age and AIx 27, 28. Hypertensive patients however, showed a general 
higher AIx in both groups as compared to normotensive subjects, suggesting that arterial 
aging is anticipated in hypertension. Furthermore age was a significant predictor of FMD, 
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results in line with previous studies, which showed inverse associations between age and 
endothelial function in the microcirculation 8 as well as in conduit artery 29. The mean age of 
the study population was 48 years with a range from 20 to 70 years. Since increasing age is an 
important predictor of both AIx and FMD, we cannot draw conclusions on the influence of 
the metabolic syndrome in different, especially younger age groups. Indeed, population 
studies showed that the metabolic syndrome increased the age-related deleterious effects on 
arterial stiffness in young normotensive adults 30 and it was associated with an increased 
progression of aortic stiffness with age in a 6-years follow-up, supporting premature 
senescence in these untreated and treated hypertensive patients (80% of the whole population) 
31
. 
In the whole population another important predictor for AIx was diastolic blood pressure. The 
clear association of diastolic blood pressure and AIx in both normotensive subjects and 
hypertensive patients suggests an important role of the microcirculation in determining AIx, 
therefore confirming that AIx is an index of wave reflection at the peripheral site and 
subsequently a manifestation of systemic arterial stiffness 32.  
In conclusion, in our population of untreated hypertensive patients and normotensive controls, 
the presence of the metabolic syndrome does not account for a further deterioration of 
vascular structural and functional parameters. Beside age and gender, diastolic BP is the only 
significant predictor of arterial wave reflection. Aging is the main determinant of conduit 
artery endothelial function.  These results support the hypothesis that blood pressure is the 
most important component of the metabolic syndrome in defining conduit artery endothelial 
function and AIx in these subjects.  
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Chapter 3 
HABITUAL PHYSICAL ACTIVITY AND 
AUGMENTATION INDEX IN UNTREATED 
HYPERTENSIVE PATIENTS AND NORMOTENSIVE 
SUBJECTS 
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Abstract  
Background. Hypertension is associated with increased arterial stiffness and wave reflection. 
Regular physical activity has been shown to lower blood pressure and arterial stiffness in 
healthy subjects. At the present time no studies have examined the relationship between 
habitual physical activity and arterial wave reflection in hypertensive patients. The aim of this 
study was to evaluate the possible associations between habitual physical activity and 
augmentation index in patients with untreated essential hypertension in comparison with 
normotensive individuals. 
Methods. Augmentation index was determined with radial applanation tonometry in 238 
untreated hypertensive patients and 163 normotensive subjects. Habitual physical activity was 
assessed with a modified Baecke questionnaire, validated by measuring cardio-respiratory 
fitness in a subgroup (n= 60). 
Results. In hypertensive patients, augmentation index did not differ between active and 
sedentary subjects and none of the physical activity indexes resulted as significant predictor 
of augmentation index. In the normotensive group, physically active subjects showed 
significantly lower values of augmentation index as compared to their sedentary peers. 
Moreover, sport index resulted as an independent predictor of augmentation index. 
Conclusions. In normotensive subjects, physical activity was associated with a lower 
augmentation index, whereas in untreated hypertensive patients this association was not 
evident. Thus, untreated essential hypertension seems to level out the beneficial impact of 
habitual physical activity on augmentation index. Further research should investigate the 
effect of physical activity, in regard with the type and level of physical activity required to 
exert a beneficial effect in hypertensive patients in the absence or presence of 
pharmacological treatment. 
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Introduction 
Hypertension is a powerful determinant of cardiovascular risk 1-3. Most of the cardiovascular 
complications associated with hypertension are caused by alterations in vascular structure and 
function. Indeed, hypertension is associated with increased arterial stiffness and wave 
reflection 4, 5. Sustained elevations in blood pressure can also lead to large artery stiffness and 
this in turn can accelerate the development and progression of systolic hypertension 5, 6. This 
pathological process contributes to hypertensive target organ damage 7, 8 with a subsequently 
increase in morbidity and mortality 4, 7.  
It is well known that life-style habits and modifications are important in the prevention and 
treatment of hypertension 3. Moreover, regular physical activity plays a major role in the 
prevention and reduction of cardiovascular disease 9, 10. Longitudinal studies have indicated 
that higher levels of physical activity or fitness are associated with a lower incidence of 
hypertension 11. It has been demonstrated that aerobic exercise has a blood pressure lowering 
effect in hypertensive patients as well as in normotensive subjects 12, 13. Available evidence 
indicates that in physically active adults the age-related increase in arterial stiffness was 
attenuated as compared to their sedentary peers 14, 15. An observational study conducted in a 
cohort of men and women free of cardiovascular disease, showed a weak association between 
habitual physical activity and arterial distensibility 16. On the other hand, an intervention trial 
conducted in a relatively healthy middle-aged population showed that an increased walking 
frequency was associated with reduced vascular stiffness 17. Finally, in patients with isolated 
systolic hypertension, short-term aerobic training did not modify large-artery stiffening 18, 19. 
At the present time none of these studies has investigated the effect of habitual physical 
activity on arterial wave reflection in hypertensive patients. Therefore, the aim of this study 
was to evaluate the possible associations between habitual physical activity and augmentation 
index in patients with untreated essential hypertension in comparison with normotensive 
individuals. 
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Methods 
Study population 
In this cross-sectional study, 238 consecutive essential hypertensive (HT) patients between 20 
and 70 years of age were recruited for the study from February 2003 to December 2005. 
Patients with essential hypertension were recruited from the newly diagnosed cases in our 
outpatient clinic and were enrolled if sitting clinic blood pressure (after 10 minutes of rest) 
was consistently found to be equal to or greater than 140/90 mmHg, confirmed in two 
separate occasions within one month, according to ESH-ESC guidelines 3. Patients had never 
been treated (n=159) or had a history of discontinuous treatment (n=79), with a 
pharmacological washout for at least 3 weeks before entering the study. Patients with prior 
cardiovascular events, cardiovascular diseases or other diseases requiring medical treatment, 
were excluded for the study.  
One hundred sixty three controls subjects were recruited and defined as normotensive (NT) 
according to the absence of familial history of essential hypertension and blood pressure 
values below 140/90 mmHg. The study complied with the declaration of Helsinki of the 
World Medical Association and the local ethical committee approved the protocol. All study 
participants gave written informed consent for the study. 
Hemodynamics 
Blood pressure was calculated as the mean value of three measurements made at 3 minutes 
interval by an automatic device at the dominant arm (OMRON-950 CP). Radial tonometry 
was performed by one trained operator (Y.P.). After an overnight fast, measurements were 
performed with the subjects in supine position in a quiet, air-conditioned room (22-24°C). A 
hand held probe was placed on the radial artery from the wrist of the dominant arm and 10-15 
subsequent images were recorded. Pulse Wave Analysis (PWA) (SphygmoCor, AtCor 
Medical, Sydney, Australia) was used to transform the radial pressure waveform into the 
aortic pressure waveform by using a validated transfer function 20. Three successive 
measurements were recorded. Augmented pressure (AP) was calculated as the difference 
between the second systolic peak and the first systolic peak and augmentation index (AIx) 
was calculated as the ratio between AP and pulse pressure (PP). Since AIx in this study 
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correlated with heart rate, values were normalized at a heart rate of 75 beats/min. Coefficient 
of variation for repeated measures of AIx in our lab is 14%. 
Habitual physical activity 
Habitual physical activity was measured by interviewing all study subjects with the Baecke 
questionnaire 21. The questionnaire assesses 16 different items concerning habitual physical 
activity. Responses are coded on a 5-point scale, which provides a guide of general physical 
activity. The Baecke score is based on three components of physical activity:  an 
occupational/work index, a sport index and a leisure time index. The total index of habitual 
physical activity was calculated by summing up the individual scores. 
To validate the use of the questionnaire in our population, cardio respiratory fitness (VO2max) 
was measured in a subgroup of 60 subjects, 29 normotensive subjects and 31 hypertensive 
patients, with a graded exercise test (cycle ergometer). Initial resistance was set at 25 W and 
25 W stepwise increments every 2 minutes. Blood pressure was measured every last 30 
seconds of the different steps. No significant differences were found in age- and gender 
adjusted levels of VO2 max between HT and NT groups (27.2 and 27.2 ml/min/kg, 
repectively). VO2 max was significantly correlated with total index (R=0.47; p<0.01) and 
sport index (R=0.50; p<0.01), but not with leisure time index (R=0.22; p= ns) and work index 
(R=0.10; p=ns).  
Blood samples were collected following an overnight fast to measure lipid and glucose 
profile. Creatinine clearance was evaluated according to simplified MDRD formula 22. 
Information on current smoking status (smoker/non smoker) was also collected.  
Statistical analysis. 
Mean levels of selected clinical characteristics in hypertensive patients and normotensive 
subjects were computed and compared across the two groups by covariance analysis, 
introducing in each model terms for age and gender. To explore the effect of habitual physical 
activity, this parameter was added as a categorical variable (active/sedentary) in the analysis, 
being sedentary classified as the absence of sport activities. Differences between groups 
(gender and physical activity status) were tested by ANCOVA, adjusting for possible 
confounders.  
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Simple regression analysis was used to examine clinical and lifestyle characteristics 
influencing AIx. Multiple linear regression analysis was performed in the whole study group 
and separately in HT patients and NT subjects, including in the final model all variables that 
in the preliminary regression analysis were related to AIx. Differences were considered 
statistically significant when p < 0.05. All statistical procedures were performed using the 
Statview program (Abacus Concepts, Inc., SAS Institute, Cary, NC) and SAS statistical 
software (SAS/STAT version 9.1). 
Results 
Clinical characteristics and physical activity indexes are shown in Table 1 separately for HT 
patients and NT subjects. Blood pressure values were significantly higher in HT patients than 
NT subjects, while the differences in gender distribution, age and creatinine clearance were 
not statistically significant. No differences emerged for BMI, plasma glucose, lipid profile or 
smoking habits between the two groups. No significant differences were found in levels of 
total physical activity and sport indexes. The work index resulted higher in HT patients, 
whereas the leisure time index resulted higher in NT subjects (Table 1). 
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Table 1 - Age- and gender –adjusted mean values of selected clinical characteristics and physical 
activity indexes in HT and NT subjects. 
 Normotensive subjects 
N = 163 
Hypertensive patients 
N = 238 
P value 
Gender (male/female) % 
Smoking (yes/no) % 
Age (years) 
Body mass index (kg/m2) 
Height (cm) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Total cholesterol (mmol/L) 
HDL cholesterol (mmol/L) 
Triglycerides (mmol/L) 
Plasma glucose (mmol/L) 
Creatinine clearance (ml/min) 
96/64 (39) 
31/132 (19) 
46.7±10 
26.2±2.2 
170.2±9.9 
130±10 
81±7 
5.4±0.9 
1.4±0.4 
1.4±1.5 
5.2±0.5 
89.0±14.5 
161/77 (33) 
45/193 (19) 
48.2±11 
26.2±1.9 
169.6±9.2 
155±11 
95±7 
5.3±1.0 
1.4±0.4 
1.4±1.3 
5.2±0.6 
86.3±13.9 
0.09 
0.98 
0.12 
0.89 
0.39 
<0.0001 
<0.0001 
0.81 
0.42 
0.78 
0.77 
0.06 
Habitual physical activity    
Work index 
Leisure time index 
Sport index 
Total index 
2.36±0.95 
2.57±0.75 
2.21±0.80 
7.14±1.50 
2.53±0.87 
2.44±0.62 
2.13±0.73 
7.10±1.37 
0.05 
0.05 
0.30 
0.80 
 
AIx was significantly higher in HT patients (26.9±9.6%) as compared to NT subjects 
(20.4±11.3%)  (Figure 1). Physically active HT patients did not significantly differ for AIx 
(26.6±9.4%) as compared to their sedentary peers (27.2±10.6%). According to gender, 
physically active male and female patients did not significantly differ in age, height, BMI, 
SBP, DBP, plasma glucose, total and HDL cholesterol. Moreover, physically active male HT 
patients (n=74) showed similar levels of AIx as compared to their sedentary peers (n=87). 
Furthermore, no differences were found in AIx between active (n=26) and sedentary (n=51) 
female HT patients (Figure 2).  
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Figure 1 - Augmentation index (AIx) in normotensive subjects (left, grey) and hypertensive 
patients (right, white). Data are shown as median and interquartile range. Bars represent 10th 
and 90th percentile; dots outliers. 
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Figure 2 - Adjusted mean values of augmentation index (AIx) among males and females 
according to physical activity status (active, white bars and sedentary, black bars) in 
normotensive subjects and hypertensive patients. Data are shown as mean + SEM. * Denotes a 
significant difference (p<0.05) between active and sedentary groups. 
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In the NT group, physically active subjects showed a significantly (p<0.01) lower AIx 
(17.6±9.6%) as compared to their sedentary peers (23.4±10.2%). Dividing for gender, 
physically active male subjects (n=48) were significantly (p<0.05) younger (43 vs. 48 years) 
and showed lower BMI (26.1 vs. 28.2 kg/m2), plasma glucose (5.16 vs. 5.34 mmol/L) and 
higher HDL-cholesterol (1.31 vs. 1.17 mmol/L) as compared to their sedentary peers (n=48), 
while no differences were found for height, SBP, DBP or total cholesterol. Physically active 
male NT subjects showed significantly lower AIx as compared to their sedentary peers 
(p<0.005). Adjusting for age, BMI, HDL and plasma glucose the difference remained 
significant (p<0.05) (fig. 2). Active female NT subjects (n=22) showed lower BMI (23.9 vs. 
25.3 kg/m2) and plasma glucose (4.82 vs. 5.11 mmol/L), whereas no differences were found 
for age, height, SBP, DBP, total and HDL cholesterol as compared with sedentary female NT 
subjects (n=45). Physically active female subjects showed significantly (p<0.01) lower AIx as 
compared to their sedentary peers. Adjusting the values for BMI and plasma glucose the 
difference remained significant (p<0.05) (Figure 2). 
Univariate regression analysis showed that age, height, DBP and total cholesterol were 
significant associated with AIx in NT subjects and HT patients (Table 2). Total physical 
activity index and sport index of physical activity were inversely related with AIx in NT and 
HT (Table 2). These associations were more pronounced in NT and the correlation for total 
index and AIx resulted significantly higher in NT as compared to HT (p=0.05). The work 
index showed an inverse association with AIx only in NT subjects (Table 2). In the validation 
subgroup, VO2 max was significantly inversely related to AIx in NT subjects (R=-0.56, 
p<0.05), whereas no such relationship was found in HT patients (R=0.02, p=ns). 
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Table 2 - Correlation coefficients between selected clinical and lifestyle characteristics and 
augmentation index. 
Augmentation Index  
Normotensive n = 163 Hypertensive n = 238 
Age 
Height 
Systolic blood pressure  
Diastolic blood pressure  
Total cholesterol  
Creatinine clearance  
Smoking  
Total index 
Work index 
Leisure time index 
Sport index 
0.52* 
-0.46* 
0.13  
0.27* 
0.18† 
-0.14  
-0.12 
-0.35* 
-0.20† 
-0.13 
-0.30* 
0.38* 
-0.50* 
0.20* 
0.17† 
0.20* 
-0.11 
-0.09 
-0.17† 
0.11 
-0.10 
-0.16† 
* p<0.005, † p<0.05. 
In the multiple regression models for the evaluation of factors predicting AIx among HT 
patients, increasing age, DBP, female gender, height and smoking, remained significant 
predictors, while the sport index was no longer a significant predictor (Table 3). Separate 
analyses among NT subjects showed that increasing age, DBP, female gender, height and a 
low sport index (Table 3) were positive predictors of AIx. 
In the whole group increasing age (p<0.0001), female gender (p<0.0001), presence of 
hypertension (p<0.0001), height (p<0.001), low total and sport index (p<0.05) all resulted 
significant positive predictors of AIx. 
Chapter 3 
 59 
Table 3 - Predictors of augmentation index in the two separate categories based on a single 
multivariate model (upper panel) and a similar model including 3 separate terms for physical 
activity indexes instead of a total single index (lower panel) 
Normotensive subject Hypertensive patients  
β p Β p 
Gender (male) 
Age 
Height  
Systolic blood pressure 
Diastolic blood pressure  
Total cholesterol  
Creatinine clearance  
Smoking 
Total index  
-6.31 
0.44 
-0.20 
-0.13 
0.57 
0.02 
-0.02 
-0.51 
-0.70 
<0.01 
<0.0001 
<0.05 
0.18 
<0.0001 
0.31 
0.64 
0.78 
0.14 
-6.18 
0.34 
-0.23 
-0.02 
0.38 
0.02 
0.03 
3.55  
-0.44 
<0.0001 
<0.0001 
<0.01 
0.62 
<0.0001 
0.10 
0.39 
<0.01 
0.22 
Work index 
Leisure time index 
Sport index 
0.28 
-0.64 
-1.93 
0.70 
0.56 
<0.05 
-0.03 
-1.04 
-0.33 
0.95 
0.18 
0.64 
 
Discussion 
The aim of this cross-sectional study was to evaluate the possible associations between 
habitual physical activity and AIx, an index of arterial wave reflection and arterial stiffness in 
untreated HT patients in comparison with NT individuals.  
HT patients showed a higher AIx than NT subjects, a result in agreement with previous 
studies 5, 8. When HT patients were divided according to habitual physical activity status, no 
difference was found in AIx between active and sedentary subjects. This result remained the 
same after performing separate analysis for male and female patients. Furthermore, in the HT 
group the different modalities of habitual physical activity were weakly associated with AIx 
and none of the physical activity indexes resulted as significant predictor of AIx in the 
multivariate analysis.  
On the contrary in the NT group, physically active males and females showed significantly 
lower values of AIx as compared to their sedentary peers. Moreover, AIx was significantly 
related with total index of habitual physical activity, work index and sport index, the latter 
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resulting as an independent predictor of AIx in the multivariate analysis. Therefore, the major 
finding of this study is that while among NT subjects physical activity status is associated 
with attenuation in AIx, in untreated HT patients this association is not present, despite the 
same level of physical activity in the two groups.   
To our knowledge this is the first study to investigate the relationship between habitual 
physical activity and arterial wave reflection in HT patients. Available intervention studies 
aimed to improve arterial stiffness were performed in small groups of patients with isolated 
systolic hypertension 18, 19. It was shown that short-term, physical activity of moderate 
intensity did not change systemic arterial compliance or aortic pulse wave velocity (PWV) in 
female and male patients 18. Similarly, aerobic exercise did not affect aortic PWV and carotid 
AIx in post-menopausal women 19. Therefore, the negative results in the HT patients of our 
study support the evidence that moderate physical activity might not be sufficient to improve 
arterial stiffness or wave reflection in patients with hypertension.  Since sustained untreated or 
poorly treated elevations of blood pressure increase arterial stiffness 23, it is conceivable that 
the degree of physical activity is not effective to counterbalance the increase in AIx in HT 
patients.  
On the other hand, results obtained in the group of NT subjects are in line with a study 
conducted in a cohort of young adults, showing a relationship between sport-related physical 
activity and aortic PWV 24. The latter association was strongly mediated by cardio-respiratory 
fitness. Furthermore, a cross-sectional study conducted in a cohort of men and women free of 
cardiovascular disease, showed a weak association between habitual physical activity and 
carotid distensibility 16. Finally, one study showed that the age-related increase in arterial 
stiffnes was not observed in highly physically active women 15. 
Studies conducted to evaluate the effect of high intensity exercise on arterial stiffness showed 
that older men who performed endurance exercise had lower levels of aortic PWV and AIx 
than their sedentary peers 14. A lower AIx was also demonstrated in competitive endurance 
athletes as compared to recreationally active individuals 25. Finally, concerning intervention 
studies, it has been demonstrated that a moderate intensity and walking type of physical 
activity increased carotid arterial compliance in previously sedentary, but healthy middle-aged 
and older men 26.  
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Sport index was the most important predictor of AIx among the indexes of habitual physical 
activity, suggesting that sports’ more than work or leisure time activities have an impact on 
vascular function. The level of physical activity associated to lower AIx in active NT subjects 
corresponds to moderate-intensity sport activities (jogging, aerobics, cycling and swimming) 
at a mean level of 3 hours per week, which is in agreement with the current guidelines 
recommendations 27.  
Possible explanations for the beneficial effect of physical activity on AIx could reside in a 
protective effect on conduit artery stiffness and/or vascular reactivity of the microcirculation, 
leading to a different site of wave reflection. These mechanisms could be mediated by a 
decrease in sympathetic tone and improvement in endothelial function. In this line, it has been 
shown that sympathetic activation could alter the compliance of the arterial system 28 and it is 
well established that physical activity is able to lower sympathetic activation 29, 30. Moreover, 
it was shown that regular physical activity in elderly athletes prevented in part the age-
induced endothelial dysfunction in conduit arteries 31 and the forearm microcirculation 32. The 
before mentioned mechanisms could alternatively explain the lack of association of physical 
activity and AIx in hypertensive patients, since hypertension has been associated with an 
acceleration of endothelial dysfunction 33 and increased sympathetic nerve activity 34.  
Important confounders for AIx were age, gender, and diastolic blood pressure. Increasing age 
was related to higher AIx in both HT patients and NT subjects, confirming previous 
observations of a positive association between increasing age and AIx 35-37. Furthermore, 
female gender was associated with higher levels of AIx in both NT and HT groups. Indeed, it 
is well known that women have smaller and stiffer blood vessels resulting in an earlier return 
of the reflected wave 38. Finally, the association of diastolic blood pressure and AIx in both 
NT and HT suggests an important role of the microcirculation in determining AIx, therefore 
confirming that AIx is an index of wave reflection at the peripheral site and subsequently a 
manifestation of systemic arterial stiffness 39. 
The major limitation of the present study is that physical activity levels were assessed 
indirectly by questionnaire. However, the results were confirmed in the relatively small 
subgroup in which cardio-respiratory fitness was assessed. Moreover, the cross-sectional 
design of this study does not allow us to draw conclusions on the dose-effect relation of 
physical activity and AIx in both NT subjects and HT patients.  
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In conclusion, the present study suggests a protective effect of habitual physical activity on 
increased wave reflection in NT subjects, whereas the presence of a cardiovascular risk factor 
such as untreated essential hypertension seems to level out this beneficial effect. Our findings 
could have implications for the treatment of hypertension. However, further research should 
be carried out to investigate the effect of physical activity in hypertensive patients, especially 
in regard with the type and level of physical activity required to exert a beneficial effect on 
arterial stiffness in the absence or presence of pharmacological treatment. 
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Chapter 4 
PHYSICAL ACTIVITY, PLASMA ANTIOXIDANT 
CAPACITY AND ENDOTHELIUM-DEPENDENT 
VASODILATION IN YOUNG AND OLDER MEN 
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Abstract 
Background. Sedentary aging is associated with oxidative stress and endothelial dysfunction. 
The aim of this study was to evaluate the relationship between chronic physical activity, 
plasma antioxidant status and conduit artery endothelial function in young and older healthy 
men. 
Methods. In young (n=16) and older athletes (n=16) and matched healthy sedentary subjects, 
endothelium-dependent flow-mediated dilation (FMD) and endothelium-independent response 
to glyceryl trinitrate (GTN, 400 µg) were measured in the brachial artery from high-resolution 
ultrasound. Plasma malondialdehyde (MDA) and antioxidant capacity as Total Oxyradical 
Scavenging Capacity (TOSC) were also evaluated.  
Results. FMD resulted lower (<0.01 or less) in sedentary older subjects (2.3±1.0%) as 
compared with older athletes (5.3±3.2%) and both sedentary (5.4±2.0%) and trained 
(6.1±3.2%) young subjects. Sedentary older subjects showed higher (p<0.05 or less) MDA 
levels and lower (p<0.0001) plasma antioxidant capacity as compared to the other subgroups, 
while in older athletes MDA levels and antioxidant capacity were similar to those observed in 
the young subgroups. In the whole group, FMD, but not GTN, was negatively related to age 
(r=-0.31, p<0.05) and directly related (p<0.01 or less) to VO2max (r=0.49) and TOSC against 
peroxyl (r=0.69) and hydroxyl radicals (r=0.53). In the multivariate analysis, TOSC against 
peroxyl radicals resulted as the most significant predictor of FMD (R2=0.60; p=0.003). 
Conclusion. These results suggest that regular physical activity is associated with preserved 
antioxidant defenses and endothelial function in older individuals. 
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Introduction 
Endothelium plays an important role in the local regulation of vascular tone and structure, 
mainly by nitric oxide (NO) synthesis and action.1 Endothelial dysfunction has been 
associated with several risk factors for atherosclerosis including dyslipidemia, diabetes, 
essential hypertension and smoking2-5. 
Aging is an independent risk factor for the development of atherosclerosis and is associated 
with a progressive decline in endothelium-dependent vasodilation in resistance6-9 and conduit 
vessels10,11. This alteration is related to a worsening of oxidative status related to both 
increased oxygen free radicals production9,11 and a gradual loss of antioxidant capacity12, 
leading together to impaired NO availability9. 
Physical training has beneficial effects on multiple cardiovascular risk factors, such as 
dyslipidemia, hypertension, diabetes, and cardiovascular events13. The effect of exercise on 
clinical outcome could also be partially related to a direct and independent positive effect of 
physical training on endothelial dysfunction in the conduit arteries14 or in the peripheral 
microcirculation15-18. Thus, regular physical activity is associated with an increased 
endothelium-dependent vasodilation19 and NO availability15-18. This beneficial effect is likely 
to be related to oxidative stress since acute vitamin C administration can improve 
endothelium-dependent vasodilation in the peripheral microcirculation17 and conduit arteries11 
in old sedentary subjects while ineffective in athletes of the same age. On this regards 
available evidence supports the possibility that the beneficial effect of physical exercise on 
oxidative stress might be related to increased antioxidant defenses20.  
However no single study has simultaneously addressed the relationship between aging, 
oxidative stress, antioxidant defenses and physical activity on endothelial function in humans. 
Therefore, the aim of the present study was to evaluate in young and older athletes and 
healthy sedentary subjects the relationship between flow-mediated endothelium-dependent 
dilation (FMD) of the brachial artery, a plasma marker of oxidative stress and plasma 
antioxidant activity.  
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Methods 
Study population 
The study population included young (n=16 males, mean age 33.4±6.7 years) and older 
athletes (n=16 males, mean age 63.6±6.1 years) and matched healthy sedentary subjects (table 
1). Subjects were included in the study in the absence of cardiovascular disease or risk factors. 
Clinical history, physical examination, basal and stress electrocardiogram, blood chemistry 
and biochemistry were performed. All the subjects were non-smoking and had no medication 
or supplementation of vitamins. 
Athletes were considered for the study when maximal oxygen uptake (VO2max), assessed by 
a graded exercise test (cycle ergometer), was greater than 50 ml/min/Kg, whereas sedentary 
subjects were included when VO2max was lower than 45 ml/min/Kg21. Young and older 
endurance-trained subjects performed exercise for 11±2 and 37±5 years, respectively. They 
performed vigorous endurance exercise (>5 times/week) and were active in national and 
international road running races and were recruited from running clubs throughout the 
surrounding regions and from the National Veterans Sport Club of Pisa. Sedentary subjects 
were recruited through various forms of advertisements. The protocol was approved by the 
Ethics Committee of the University of Pisa and all patients gave written consent to the study. 
Experimental procedure 
Vascular ultrasound scans were performed in the morning, with subjects supine, in a quiet air 
conditioned room (22-24°C). A B-mode scan of the right brachial artery was obtained in 
longitudinal section between 5 cm and 10 cm above the elbow using a 7.0 MHz linear array 
transducer and a standard AU5 Armonic system (ESAOTE Biomedica, Florence, Italy) as 
already described4. Briefly, the transducer was held at the same point throughout the scan by a 
stereotactic clamp. End-diastolic frames were acquired every second on a personal computer 
using a commercial software program (miroVIDEO DC30/plus, Pinnacle Systems GmbH, 
Braunschweig, Germany). Arterial flow velocity was obtained by pulsed Doppler signal at 
70° to the vessel with the range gate (1.5 mm) in the center of the artery. A cuff was placed 
around the forearm just below the elbow. 
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Experimental protocol 
Endothelium-dependent response was assessed as dilation of the brachial artery induced by 
increased flow (flow mediated dilation, FMD)2,22. After 1 minute of baseline acquisition, the 
cuff was inflated for five minutes and then deflated to induce reactive hyperemia (RH). 
Endothelium-independent dilation was obtained by sublingual administration of glyceril 
trinitrate (GTN, 400 µg). Brachial artery diameter was measured on acquired frames by a 
computerized edge detection system23. FMD and response to GTN were calculated as the 
maximal percent increase in diameter above baseline after RH and GTN administration, 
respectively. 
Blood flow volume was calculated by multiplying Doppler flow velocity (corrected for the 
angle), heart rate and vessel cross-sectional area (pir2) at baseline and within 15 seconds after 
cuff release to calculate RH (as percent increase in blood flow).  
Blood samples were collected following a 12-h overnight fast. The Total Oxyradical 
Scavenging Capacity (TOSC) assay was used for measuring the total antioxidant capacity of 
human plasma against peroxyl radicals (ROO·) and hydroxyl radicals (HO·, bottom) by gas-
chromatographic analysis (HP 6890 Series, Andoven, Mass.), as previously described24,25. 
Results were expressed in TOSC units per ml of plasma. In our lab variability of TOSC assay 
was < 5%26. 
Oxidative stress was evaluated by measuring lipid peroxidation of polyunsaturated fatty acids 
in terms of thiobarbituric acid-reactive substances and converted in malondialdehyde 
(MDA)27. The amount of lipid peroxidation was reported as micromolar MDA equivalents. 
Statistical Analysis 
Data were expressed as mean ± standard deviation (SD). ANOVA method was used to assess 
the mean differences between groups. Differences were considered significant when p<0.05. 
Interactions between variables were calculated by correlation and multiple regression 
analyses. All statistical procedures were performed using the StatView program (Abacus 
Concepts, Inc., SAS Institute, Cary, NC). 
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Results 
Clinical characteristics of the study population are shown in table 1. Sedentary subjects and 
athletes were matched for arterial blood pressure and body mass index. According to the 
inclusion criteria, VO2max was higher in trained subjects as compared to sedentary 
subgroups. Athletes also showed a lower resting heart rate as compared to non-athletes. The 
sedentary older subgroup showed significantly lower HDL and higher LDL cholesterol as 
compared to the other subgroups. 
Table 1 - Clinical characteristics of the study population (mean±SD) 
 Young 
Sedentary 
Males, n=16 
Older 
Sedentary 
Males, n=16 
Young 
Athletes 
Males, n=16 
Older 
Athletes 
Males, n=16 
Age (years) 
BMI (kg/m2) 
Heart rate (bpm) 
SBP (mmHg) 
DBP (mmHg) 
Glucose (mg/gL) 
Total cholesterol (mg/dL) 
HDL cholesterol (mg/dL) 
LDL cholesterol (mg/dL) 
VO2max (ml/kg min) 
BA diameter (mm) 
Reactive hyperemia (%) 
34.1±7.5 
23.1±1.2 
61.5±4.6 
119.3±4.5 
75.3±7.6 
91.8±7.7 
183.9±10.5 
60.5±8.7 
99.9±12.2 
37.9±2.9 
5.02±0.53 
534±211 
63.7±4.3 
24.2±1.3 
65.3±9.2 
126.2±5.4 
78.7±5.8 
93.1±9.0 
187.7±12.0 
43.4±8.7# 
109.4±10.2# 
28.0±5.9# 
5.07±0.71 
513±222 
33.4±6.7 
23.4±0.7 
49.6±4.3* 
119.4±4.3 
75.5±3.1 
89.6±8.4 
182.1±9.0 
63.3±11.1 
101.7±12.1 
66.8±2.9° 
5.43±0.57 
567±190 
63.6±6.1 
23.9±1.0 
53.9±5.2* 
126.3±4.2 
78.2±5.2 
92.0±0.9.1 
185.9±11.3 
58.9±11.3 
101.4±12.8 
54.7±3.7 
5.44±0.74 
565±227 
BMI = body mass index; SBP = systolic blood pressure; 
DBP = diastolic blood pressure; VO2 max = maximal O2 uptake; BA = brachial artery 
*p<0.0001 vs sedentary subgroups, °<0.0001 vs. older subgroups, 
#<0.0001 vs other subgroups.  
 
Older sedentary subjects showed lower FMD as compared to older athletes and both young 
subgroups (figure 1), whereas no differences were shown in the response to GTN (figure 1). 
FMD, as well as response to GTN, were similar in young and older athletes. RH and brachial 
artery diameter were similar in the four study groups (table1). 
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Figure 1 - Flow-mediated dilation (FMD) and glyceryl trinitrate (GTN) induced dilation, 
expressed as maximal percentage change of brachial artery diameter, in the young and older 
subgroups of athletes and sedentary subjects (mean±SD). *p<0.001 vs other subgroups 
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Older sedentary subjects exhibit lower TOSC values vs. ROO· and vs. HO· (-48% and -61%, 
respectively) and higher MDA plasma levels (+26%), as compared to the young sedentary 
subgroup and both trained subgroups (figure 2). Older athletes showed significantly lower 
TOSC vs. ROO· and vs. HO· but not significantly higher MDA levels as compared to young 
athletes, whereas this difference was not shown between older athletes and young sedentary 
subjects (figure 2). 
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Figure 2 - Plasma Total Oxyradical Scavenging Capacity (TOSC) against peroxyl radicals 
(ROO•) and hydroxyl radicals (HO•), and plasma malondialdehyde (MDA) in the young and 
older subgroups of athletes and sedentary subjects (mean±SD). *p<0.001 vs others subgroup, 
#p<0.01 vs young sedentary subjects, °=p<0.01 vs older athletes. 
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Univariate and multivariate analysis: whole population 
In the whole population FMD, but not response to GTN, was significantly related to VO2max, 
TOSC vs. ROO· and vs. HO· and inversely related to age (r=-0.31; p<0.05) (figure 3). FMD 
was also positively related to HDL cholesterol (r=0.37; p<0.01) and inversely related to LDL 
cholesterol (r=-0.27; p<0.05). VO2max was significantly related to TOSC vs. ROO· (r=0.73; 
p<0.001) and vs. HO· (r=0.72; p<0.001) and inversely related to MDA levels (r=-0.30; 
p<0.05). Furthermore, age was directly related to MDA (r=0.44; p<0.01), and inversely 
related to TOSC vs. ROO· (r=-0.53; p<0.001), and vs. HO· (r=-0.57; p<0.001) and VO2max 
(r=-0.32; p<0.05). 
In a multivariate analysis both age and VO2 max resulted as significant predictors of FMD 
(R2= 0,25; p= 0.0001). However, VO2 max accounted for a larger amount of variance in FMD 
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(R2=0.13, p= 0.004) than age (R2= 0.07; p=0.04). Including all significant variables, only 
TOSC value vs. ROO· resulted as a significant predictor of FMD (R2=0.60; p=0.003). 
Figure 3 - Correlation analysis between flow mediated dilation (FMD), expressed as maximal 
percentage change of brachial artery diameter, maximal oxygen uptake (VO2max, top), and 
plasma Total Oxyradical Scavenging Capacity (TOSC) against peroxyl radicals (ROO•, middle) 
and hydroxyl radicals (HO, bottom). 
1
2
3
4
5
6
7
8
9
10
10 20 30 40 50 60 70 80
VO2 max (ml/Kg/min)
1
2
3
4
5
6
7
8
9
10
4 6 8 10 12 14 16 18 20 22 24 26
TOSC vs ROO· (units/ml)
1
2
3
4
5
6
7
8
9
10
0 2 4 6 8 10 12 14 16
TOSC vs OH· (units/ml)
FM
D 
(%
)
FM
D 
(%
)
FM
D 
(%
)
r=0.53; p=0.001
 
Subgroup’s analysis  
In the sedentary subjects, FMD was inversely related to age (figure 4). It was also related to 
VO2max (r=0.51; p<0.001), TOSC vs. ROO· (r=0.70; p<0.001) and vs. HO· (r=0.47; p<0.01) 
and HDL (r=0.48; p<0.01). In the multivariate analysis TOSC value vs. ROO· resulted as the 
only significant predictor of FMD (R2=0.64; p=0.02).  
In the athletes, FMD was not related to age (figure 4), while it was related to TOSC vs. ROO· 
(r=0.37; p=0.05) and VO2max (r=0.34; p=0.05).  
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Figure 4 - Correlation analysis between flow mediated dilation (FMD, maximal percent 
increase) and age in sedentary subjects (top) and athletes (bottom). 
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Discussion 
The present study indicates that advancing age is characterized by an impairment of 
endothelium-dependent FMD of conduit arteries with a parallel attenuation of plasma 
antioxidant capacity and increased production of MDA, a marker of oxidative stress. In 
contrast, in older subjects who regularly perform aerobic endurance training FMD is 
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preserved. This beneficial effect seems to be related to a higher plasma antioxidant capacity, 
which can counteract on the oxidative stress production associated with aging. 
Older sedentary subjects showed a reduced endothelium-dependent FMD as compared to 
young subjects, while endothelium-independent vasodilation was similar. These findings 
confirm previous research showing the presence of impaired endothelium-dependent 
vasodilation in the brachial artery of older sedentary subjects10,11. This age-related impairment 
of endothelium-dependent vasodilation could be caused either by a decreased production of 
NO, due to changes in expression and/or activity of eNOS28,29 or an increased degradation of 
NO, by reactive oxygen species30-32.  
In the population of sedentary subjects, the older subgroup exhibited a higher MDA, a plasma 
marker of oxidative stress, as compared to the young subgroup. Moreover, endothelium-
dependent FMD was inversely related to MDA, thus supporting the possibility that the age-
related increase of oxidative stress could be a promoter of endothelial dysfunction. These 
results are in line with previous studies showing that ascorbate can acutely restore 
endothelium dependent vasodilation in the brachial artery11 and in the forearm 
microcirculation17 of old sedentary subjects, but not old athletes.  
Moreover, aging is associated with a gradual loss of antioxidant capacity12, which normally 
provides cellular protection against reactive oxygen species. The evaluation of the TOSC 
assay, a highly reproducible method for quantitative measurement of the capacity of a 
molecule or a tissue to neutralize various classes of reactive oxygen species25, showed that 
plasma antioxidant defense capacity against both peroxyl and hydroxyl radicals is reduced in 
sedentary aging. In addition, plasma antioxidant defense capacity against peroxyl radicals was 
only a negative predictor of FMD, suggesting that the loss of antioxidant capacity associated 
with aging might represent the main determinant of age-related impairment in endothelium-
dependent vasodilation.  
In line with previous studies11,19 older athletes showed a higher FMD than sedentary matched 
subjects. Moreover, in older athletes FMD was not significantly different in respect to both 
young subgroups, confirming that endothelial dysfunction is slowed down in older subjects by 
performing endurance exercise training for many years. Thus, the shown beneficial effects of 
regular dynamic physical exercise are in line with previous evidence obtained in both conduit 
arteries14 and peripheral microcirculation15-18. However, the interesting and novel finding of 
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this study is that preserved FMD in older athletes coincides with a higher antioxidant capacity 
and lower oxidative stress as compared to older sedentary subjects.  
Although it has been suggested that acute bouts of exercise can cause oxidative stress by 
increasing LDL susceptibility to oxidation or vascular superoxide production33, chronic 
exercise exerts beneficial effects on oxidative stress ameliorating lipid profile, a phenomenon 
related to physical activity34 or increasing antioxidant defenses20. In our population maximal 
oxygen uptake was positively related to HDL and inversely related to LDL cholesterol. HDL-
cholesterol was strongly related to plasma antioxidant capacity, supporting the hypothesis that 
regular endurance training could reduce the susceptibility to oxidative stress by modifying 
lipid profile. However, since plasma antioxidant capacity against peroxyl radicals was the 
only significant predictor of FMD, it is conceivable that other mechanisms might account for 
this effect, including an up-regulation of superoxide dismutase35 and-or other antioxidant 
defenses36,37. 
It is interesting to observe that young athletes have higher TOSC plasma levels as compared 
to their sedentary peers, while FMD was not significantly different (6,2% vs 5,4%, 
respectively) in the two subgroups. This discrepancy might be tentatively explained by the 
possibility that while antioxidant defenses are susceptible to increase, FMD may reach 
maximum physiological values which is hard to increase. Another explanation could be 
related to the evidence that individuals undergoing exercise training have high levels of 
antioxidant enzymes and nonenzymatic antioxidants, causing a greater resistance to exercise-
induced or -imposed oxidative stress20. Presumably, these adaptations result from cumulative 
effects of repeated exercise bouts on the gene expression of antioxidant enzymes20 despite the 
observed low oxidative level. 
In conclusion, preserved antioxidant capacity and endothelium-dependent vasodilation found 
in older athletes suggest that chronic physical activity can counteract on the age-related 
endothelial dysfunction which characterizes sedentary aging, probably by maintaining plasma 
antioxidant defenses and therefore preventing oxidative stress. 
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Chapter 5 
REGULAR INTAKE OF ANTIOXIDANT VITAMINS, 
AUGMENTATION INDEX AND ENDOTHELIAL 
FUNCTION IN NORMOTENSIVE SUBJECTS AND 
ESSENTIAL HYPERTENSIVE PATIENTS 
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Abstract 
Background. Essential hypertension is characterized by early vascular alterations such as 
endothelial dysfunction, increased arterial stiffness and wave reflection. Since these 
alterations are mediated by increased oxidative stress, the aim of the study was to evaluate the 
possible associations of daily dietary intake of the antioxidants vitamins C and E with 
augmentation index and endothelial function in untreated essential hypertensive (HT) patients 
and normotensive (NT) subjects. 
Methods. Dietary intake of major nutrients, total caloric intake and antioxidant vitamins were 
assessed with the Italian EPIC questionnaires in 196 untreated HT patients and 130 NT 
subjects. Augmentation index (AIx) was determined with radial applanation tonometry. 
Endothelium-dependent response was assessed as flow mediated dilation (FMD) of the 
brachial artery by high ultrasound ultrasounds and computerized analysis (automatic edge 
detection system) of brachial artery diameter modifications (maximal percentage increase in 
diameter). Endothelium independent response was assessed by 25 µg of sublingual glyceril 
trinitrate (GTN). 
Results. AIx was significantly higher in HT patients (26.9±9.6%) as compared to NT subjects 
(20.4±11.3%). FMD resulted significantly lower (5.0±2.5 vs 6.2±2.7; p<0.001), whereas 
response to GTN was similar. Estimated intake of vitamin C was quite similar in HT patients 
and in NT subjects (median 146.4± 68.7 mg/day and 149.1± 84.0 mg/day, respectively). 
Intake of vitamin E was also similar (median 8.68± 2.7 mg/day and 8.63± 2.9 mg/day, 
respectively). These intakes are in agreement with those commonly consumed in a general 
Italian population. Multivariate analysis adjusted for smoking, physical activity status and 
total caloric intake showed that levels of Vitamin C or E intake were not significant predictors 
for AIx in both HT patients and NT subjects. Moreover, levels of Vitamin C or E intake were 
not significant predictors for FMD in both groups. 
Conclusions. This cross-sectional study showed no association between levels of regular food 
antioxidant intake, augmentation index and endothelial function in untreated HT hypertensive 
patients and NT subjects. 
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Introduction 
In the risk assessment of cardiovascular disease, different studies have been done on the 
possible effects of antioxidant vitamins, in regular food intake or as food supplements. In 
some observational studies a higher intake of antioxidant vitamins or higher plasma levels of 
antioxidants was associated with lower risk of myocardial infarction and/or stroke 1. These 
effects were demonstrated for carotene, ascorbic acid and tocopherol.  
However, other studies, which measured dietary intake or plasma levels of antioxidant 
vitamins, provided limited support for the association between increased intake of antioxidant 
vitamins and the risk of mortality2 or atherosclerosis, measured as carotid artery intima media 
3
. A similar study on the effects of vitamin E showed that both intake amount and plasma 
concentration of vitamin E were inversely associated with preclinical atherosclerosis in 
middle-aged women 4. Finally, in a study, which examined the associations between dietary 
and plasma vitamin C concentrations, authors found that markers of inflammation and 
endothelial dysfunction were lower with higher levels of vitamin C intake and plasma vitamin 
C in older men free of cardiovascular disease 5. 
Since it has been reported that oxidative stress plays a major role in the atherosclerotic 
process, it can be hypothesized that dietary intake of vitamins can have different effects on 
cardiovascular disease or vascular parameters in subjects with or without with increased 
levels of oxidative stress. In this line, it has been already shown that oxidative stress is 
increased in conditions such as hypertension 6, leading to a lower availability of nitric oxide in 
these subjects. Moreover, these patients are characterized by endothelial dysfunction 7, 8 and 
increased arterial stiffness 9, which both play a role in the atherosclerotic process.  
However, until the present time no data is available on the association of regular dietary 
intake of antioxidant vitamins, endothelial function and a marker of arterial wave reflection, 
augmentation index in essential hypertensive patients. Therefore, the aim of this study was to 
evaluate the association of dietary intake of vitamin C and E on these vascular parameters in 
untreated essential hypertensive patients as compared with normotensive subjects. 
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Methods 
Study population 
In this cross-sectional study, 196 consecutive essential hypertensive (HT) patients between 20 
and 70 years of age were recruited for the study from February 2003 to December 2005. 
Patients with essential hypertension were recruited from the newly diagnosed cases in our 
outpatient clinic and were enrolled if sitting clinic blood pressure (after 10 minutes of rest) 
was consistently found to be equal to or greater than 140/90 mmHg, confirmed in two 
separate occasions within one month, according to ESH-ESC guidelines 10. Patients had never 
been treated (n=139) or had a history of discontinuous treatment (n=60), with a 
pharmacological washout for at least 3 weeks before entering the study. Patients with prior 
cardiovascular events, cardiovascular diseases or other diseases requiring medical treatment, 
were excluded for the study.  
One hundred thirty controls subjects were recruited and defined as normotensive (NT) 
according to the absence of familial history of essential hypertension and blood pressure 
values below 140/90 mmHg. The study complied with the declaration of Helsinki of the 
World Medical Association and the local ethical committee approved the protocol. All study 
participants gave written informed consent for the study. 
Hemodynamics 
Blood pressure was calculated as the mean value of three measurements made at 3 minutes 
interval by an automatic device at the dominant arm (OMRON-950 CP). Radial tonometry 
was performed by one trained operator (Y.P.). After an overnight fast, measurements were 
performed with the subjects in supine position in a quiet, air-conditioned room (22-24°C). A 
hand held probe was placed on the radial artery from the wrist of the dominant arm and 10-15 
subsequent images were recorded. Pulse Wave Analysis (PWA) (SphygmoCor, AtCor 
Medical, Sydney, Australia) was used to transform the radial pressure waveform into the 
aortic pressure waveform by using a validated transfer function 11. Three successive 
measurements were recorded. Augmented pressure (AP) was calculated as the difference 
between the second systolic peak and the first systolic peak and augmentation index (AIx) 
was calculated as the ratio between AP and pulse pressure (PP). Since AIx in this study 
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correlated with heart rate, values were normalized at a heart rate of 75 beats/min. Coefficient 
of variation for repeated measures of AIx in our lab is 14%. 
Endothelium-dependent response was assessed as dilation of the brachial artery to increased 
flow (flow mediated dilation, FMD), as previously described 12. Briefly, a B-mode scan of the 
right brachial artery was obtained in longitudinal section between 5 cm and 10 cm above the 
elbow using a 7.5 MHz linear array transducer, held by a stereotactic clamp to ensure a 
constant image. B-mode images were triggered to the ECG signal to obtain only end-diastolic 
frames. Arterial flow velocity was obtained by pulsed Doppler signal at 70° to the vessel with 
the range gate (1.5 mm) in the center of the artery. A cuff was placed around the forearm just 
below the elbow and was inflated for five minutes at 250 mmHg and then deflated to induce 
reactive hyperemia. Endothelium-independent dilation was obtained by administration of a 
low dose (25 µg) of sublingual glyceril trinitrate (GTN).  
Brachial artery diameter (BAD) measurements were performed after studying the acquired 
frames by the computerized edge detection system 13. Baseline vessel size was considered as 
the mean of measures obtained during the first minute. FMD and response to GTN were 
calculated as the maximal percent increase in diameter above baseline. Doppler flow velocity 
was measured at baseline and within 15 seconds after cuff release. Volume blood flow was 
calculated by multiplying Doppler flow velocity (corrected for the angle) by heart rate and 
vessel cross-sectional area (pir2). Reactive hyperemia (RH) was the maximum percent increase 
in flow after cuff release as compared to baseline flow.  
Blood samples were collected following an overnight fast to measure lipid and glucose 
profile. Information on smoking status, educational level and habitual physical activity was 
also collected.  
Dietary intake of antioxidant vitamins 
Dietary intake was measured with the EPIC/Italy food frequency questionnaire, which is a 
validated semi/quantitative, self administered food frequency questionnaire 14.The self-
administered questionnaire on dietary intake contains questions on the average consumption 
frequency during the past year. Subjects could indicate their answers in portion size and times 
per day, week, month, or as never. With a specific software, total caloric intake, major 
nutrients and vitamin intake could be determined.  
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Statistical analysis. 
Due to skewed distributions, vitamin C and E levels were log transformed. Mean levels of 
selected clinical characteristics in hypertensive patients and normotensive subjects were 
computed and compared across the two groups by covariance analysis, introducing in each 
model terms for age and gender. Simple regression analysis was used to examine clinical and 
lifestyle characteristics influencing AIx and FMD. Multiple linear regression analysis was 
performed in HT patients and NT subjects, and level of vitamin C and E intake separately, 
including in the model all variables that in the preliminary regression analysis were related to 
AIx or FMD. Differences were considered statistically significant when p < 0.05. All 
statistical procedures were performed using the SAS statistical software (SAS/STAT version 
9.1). 
Results 
Clinical characteristics and levels of vitamin intake are shown in Table 1 separately for HT 
patients and NT subjects. Blood pressure values were significantly higher in HT patients as 
compared to NT subjects, as well as hematocrit levels and brachial artery diameter. Female 
gender resulted significantly higher in the NT subjects. No differences emerged for age, BMI, 
plasma glucose, lipid profile or smoking habits between the two groups. No significant 
differences were found in levels of vitamin C and E intake, total caloric intake and levels of 
physical activity (table 1). AIx was significantly higher in HT patients (26.9±9.6%) as 
compared to NT subjects (20.4±11.3%) whereas FMD resulted significantly lower (5.0±2.5 vs 
6.2±2.7; p<0.001). 
Univariate regression analysis in the HT group showed that age, gender, height, BMI, SBP, 
DBP, MAP, total cholesterol, hematocrit levels, total index of physical activity and total 
caloric intake were significant associated with AIx (Table 2). In the NT group, age, gender, 
height, BMI, DBP, MAP, hematocrit levels and total index of physical activity were 
significant related to AIx (Table 2). No significant associations were found for vitamin C and 
E intake and AIx in both groups. In the multiple regression models for the evaluation of 
factors predicting AIx among HT patients, increasing age, MAP, female gender, hematocrit 
levels and current smoking, remained significant predictors (Table 3). 
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Table 1 - Age- and gender –adjusted mean values of selected clinical characteristics and physical 
activity indexes in HT and NT subjects. 
 Normotensive subjects 
N = 130 
Hypertensive patients 
N = 196 
P value 
Age (years) 
Gender (male/female) % 
Current smoking (yes/no) % 
Ex smoking (%) 
Body mass index (kg/m2) 
Height (cm) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Total cholesterol (mmol/L) 
HDL cholesterol (mmol/L) 
Triglycerides (mmol/L) 
Plasma glucose (mmol/L) 
Hematocrit (%) 
Brachial artery diameter (mm) 
Total index physical activity 
Total caloric intake (kcal/day) 
Vitamin C intake (mg/day) 
Vitamin E intake (mg/day) 
47.1±10 
73/57 (44) 
26/104 (20%) 
32 
26.0±2.2 
171.3±9.9 
130±10 
80±7 
5.4±0.9 
1.4±0.4 
1.4±1.5 
5.2±0.5 
42.6±3.4 
4.31±0.77 
7.3±1.6 
2541±801 
149.1±84.0 
8.63±2.9 
48.2±11 
133/63 (32) 
33/163 (17%) 
41 
26.6±1.9 
171.5±9.2 
156±11 
96±7 
5.4±1.0 
1.4±0.4 
1.4±1.3 
5.2±0.6 
43.7±3.7 
4.60±0.86 
7.1±1.3 
2613±932 
146.4±68.7 
8.68±2.7 
0.31 
0.03 
0.21 
0.21 
0.12 
0.86 
<0.0001 
<0.0001 
0.89 
0.42 
0.78 
0.77 
<0.01 
0.002 
0.25 
0.47 
0.75 
0.89 
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Table 2 - Correlation coefficients between selected clinical and lifestyle characteristics and 
augmentation index. 
Augmentation Index Variable 
Normotensive n = 130 Hypertensive n = 196 
Age 
Gender 
Height 
BMI 
Systolic blood pressure  
Diastolic blood pressure  
MAP 
Total cholesterol  
Hematocrit 
Current smoking  
Total index physical activity 
Total caloric intake 
Vitamin C (mg/day) 
Vitamin E (mg/day) 
0.48* 
-0.45* 
-0.46* 
-0.09 
0.17 
0.22* 
0.45* 
0.17 
-0.22* 
0.12 
-0.35* 
-0.12 
-0.03 
-0.08 
0.38* 
-0.52* 
-0.51* 
-0.19† 
0.21* 
0.18† 
0.40* 
0.23* 
-0.39* 
-0.09 
-0.17† 
-0.14† 
-0.01 
-0.06 
* p<0.005, † p<0.05. 
Separate analyses among NT subjects showed that increasing age, MAP and female gender 
(Table 3) were positive predictors of AIx. In both groups, levels of Vitamin C or E intake 
were not significant predictors for AIx. In the NT group, β- values for levels of Vitamin C and 
E intake were both negative for AIx, but this did not reach the level of statistical significance, 
whereas in the HT group β - values showed a positive trend with AIx (Table 3). 
For FMD, univariate regression analysis group showed that age, BMI, and BAD were 
significantly inversely associated with FMD in both HT and NT subjects (Table 4). No 
significant associations were found for vitamin C and E intake and FMD in both groups. In 
the multiple regression models for the evaluation of factors predicting FMD among HT 
patients, increasing BAD, age, and current smoking remained significant negative predictors 
(Table 5). Separate analyses among NT subjects showed that increasing age, and BAD (Table 
5) were negative predictors of FMD. Finally, in both groups, levels of Vitamin C or E intake 
were not significant predictors for FMD. 
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Table 3 - Predictors of augmentation index in the two separate categories based on two separate 
multivariate models for Vitamin C and E intake. 
Normotensive subject Hypertensive patients Variable 
β p Β p 
Gender (male) 
Age 
Height  
MAP 
Total index physical activity 
Total caloric intake 
Total cholesterol 
Hematocrit 
Current smoking 
Ex smoking 
-8.16 
0.28 
-0.14 
0.51 
-0.47 
1.73 
0.02 
0.06 
-0.79 
2.21 
<0.0001 
<0.0001 
0.13 
<0.0001 
0.29 
0.48 
0.24 
0.79 
0.64 
0.14 
-5.78 
0.25 
-0.18 
0.27 
-0.70 
0.81 
0.02 
-0.53 
4.82  
1.56 
<0.001 
<0.0001 
0.02 
<0.0001 
0.12 
0.65 
0.11 
0.002 
<0.01 
0.16 
Vitamin C (mg/day) -1.97 
R2=0.60 
0.20 2.02 
R2=0.58 
0.09 
Vitamin E (mg/day) -4.05 
R2=0.60 
0.18 0.86 
R2=0.57 
0.73 
Table 4 - Correlation coefficients between selected clinical and lifestyle characteristics and flow 
mediated dilation (FMD) * p<0.005, † p<0.05. 
FMD Variable 
Normotensive n = 130 Hypertensive n = 196 
Age 
Gender 
Height 
BMI 
Systolic blood pressure  
Diastolic blood pressure  
MAP 
Total cholesterol  
Brachial artery diameter  
Current smoking  
Total index physical activity 
Total caloric intake 
Vitamin C (mg/day) 
Vitamin E (mg/day) 
-0.31* 
-0.16 
-0.05 
-0.29* 
0.02  
0.12 
0.01 
-0.08 
-0.46*  
-0.04 
0.12 
-0.10 
0.14 
0.07 
-0.33* 
-0.08 
-0.03 
-0.17* 
-0.13 
0.01 
-0.02 
-0.03 
-0.39* 
-0.08 
-0.02 
0.05 
0.04 
-0.06 
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Table 5 - Predictors of flow mediated dilation (FMD) in the two separate categories based on two 
separate multivariate models for Vitamin C and E intake. 
Normotensive subject Hypertensive patients Variable 
β p Β p 
Gender (male) 
Age 
BMI 
Brachial artery diameter 
MAP 
Total index physical activity 
Total caloric intake 
Total cholesterol 
Current smoking 
Ex smoking 
0.43 
-0.06 
-0.11 
-1.70 
0.51 
0.20 
0.31 
0.00 
-0.77 
0.67 
0.44 
<0.01 
0.08 
<0.0001 
<0.0001 
0.19 
0.69 
0.84 
0.16 
0.16 
0.47 
-0.07 
-0.03 
-1.06 
0.01 
-0.24 
0.81 
0.00 
-0.85  
-0.27 
0.27 
0.0001 
0.52 
<0.0001 
0.52 
0.08 
0.65 
0.81 
0.07 
0.46 
Vitamin C (mg/day) 0.57 
R2=0.38 
0.25 -0.01 
R2=0.26 
0.99 
Vitamin E (mg/day) -0.50 
R2=0.38 
0.61 -1.34 
R2=0.27 
0.12 
 
Discussion 
The aim of this cross-sectional study was to evaluate the possible associations between 
dietary intake of the antioxidant vitamins C and E, AIx, and FMD in untreated HT patients in 
comparison with NT individuals. The present study demonstrates that levels of vitamin C and 
E intake were not associated with augmentation index or endothelial function in untreated 
essential HT patients and NT controls.  To our knowledge no previous study has investigated 
the relationship between regular food intake of the antioxidant vitamins C and E on both 
augmentation index and endothelial function in essential HT patients. As to be expected, HT 
patients showed a higher AIx and a lower FMD than NT subjects, a result in agreement with 
previous studies 15-17.  
Our results differ from some observational studies which showed that a higher intake of 
antioxidant vitamins or higher plasma levels of antioxidants was associated with lower risk of 
myocardial infarction and/or stroke 1, effects that were demonstrated for carotene, ascorbic 
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acid and tocopherol. However, in a randomly selected community population, the association 
between increased intake of antioxidant vitamins and the risk of atherosclerosis, measured as 
carotid artery intima media thickness was found to be weak 3. A similar study showed that 
low vitamin E intake was a risk factor for early atherosclerosis, measured as carotid plaques, 
in middle-aged women 4. Finally, in a study, which examined the associations between dietary 
and plasma vitamin C concentrations, authors found that markers of inflammation and 
endothelial dysfunction, measures as tissue plasminogen activator (t-PA) antigen were lower 
with higher levels of vitamin C intake and plasma vitamin C in older men free of 
cardiovascular disease 5. 
The fact that in the present study we measured the intermediary endpoints AIx and FMD, and 
not overt atherosclerosis such as carotid plaques or stronger end-points such as stroke or 
myocardial infarction can explain the discrepancy between the results. Indeed this is the first 
study to show that there is no association found between regular antioxidant vitamin C and E 
intake and the vascular parameters augmentation index, which is a marker of arterial wave 
reflection, and endothelial function measured as FMD. In the multiple regression analysis we 
found negative standardized β-coefficients for vitamin C and E intake on augmentation index 
in the normotensive subjects, which did not reach the level of statistical significance. On the 
contrary, slightly positive β-coefficients were found in the hypertensive patients, indicating a 
possible trend for a beneficial effect in normotensive subjects, with no such effect in 
hypertensive patients. Finally, a non significant trend for a negative association between 
vitamin E intake and FMD was seen in the hypertensive group. 
As mentioned before, hypertension has been associated with endothelial dysfunction and 
increased arterial stiffness 7, 8, 18. In conditions such as hypertension, oxidative stress, defined 
as an excessive amount of oxidative substances, relative to endogenous antioxidant capacity, 
has shown to be increased resulting in a reduced NO-availability in these subjects 6, 19. It can 
be speculated that in especially hypertensive patients vitamin antioxidants in regular food are 
not able to counteract on the increase in augmentation index and endothelial dysfunction. 
Antioxidants have shown to provide vascular defense against oxidative stress by reducing free 
radicals and protecting NO from inactivation, therefore exerting its’ beneficial effects on 
vascular function and structure. Indeed, in a randomized control cross-over study we found 
that supplementation with combined vitamin C (1g) and vitamin E (400IU) improved both 
endothelial function and arterial stiffness in untreated essential hypertensive patients 
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(accepted for publication). Most likely the levels of regular food intake of vitamin C and E are 
too low to exert a beneficial effect on augmentation index and endothelial function, whereas 
combined supplementation with higher doses does have an effect. This despite the fact that 
the reported dietary intakes are in agreement with those commonly consumed in a general 
Italian population. 
One possible limitation of the present study is the fact that no measurements of plasma levels 
of vitamin C and E were performed. Since there could be a discrepancy between reported 
intake and plasma concentrations of antioxidant vitamins 20, our conclusions on the 
associations between intake of vitamin C and E  and vascular parameters can not be 
generalized for plasma concentrations of vitamins.  
In conclusion, this cross-sectional study demonstrated that no association exists between 
regular food vitamin C and E intake, augmentation index and endothelial function in 
hypertensive patients and normotensive subjects.  
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Chapter 6 
SUPPLEMENTATION WITH VITAMIN C AND E 
IMPROVES ARTERIAL STIFFNESS AND 
ENDOTHELIAL FUNCTION IN ESSENTIAL 
HYPERTENSIVE PATIENTS 
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Abstract 
Background. Essential hypertension is characterized by endothelial dysfunction, arterial 
stiffness and increased oxidative stress. We evaluated the effect of short-term combined 
treatment with the antioxidants vitamin C and E on endothelial function, arterial stiffness and 
oxidative stress in untreated essential hypertensive patients.  
Methods. A randomised, double blind, placebo controlled, crossover study design was used 
to assign 30, male, essential hypertensive patients to either vitamin C (1g) and E (400 IU) or 
placebo for 8 weeks. Endothelium-dependent response was assessed as flow mediated dilation 
(FMD) of the brachial artery. Arterial stiffness was assessed as central pulse wave velocity 
and augmentation index. Plasma markers of oxidative stress and antioxidant status were 
measured. 
Results. After vitamin supplementation, FMD significantly improved. Central PWV was 
significantly reduced, while AIx tended to decrease. Plasma vitamin levels and antioxidant 
capacity increased significantly. Levels of oxidative stress decreased. Changes in central 
PWV were related with changes in levels of oxidative stress.  
Conclusions. Combined treatment with Vitamin C and E has beneficial effects on 
endothelium-dependent vasodilation and arterial stiffness in untreated essential hypertensive 
patients. This effect was associated with changes in plasma markers of oxidative stress. 
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Introduction 
Essential hypertension is an important risk factor for cardiovascular disease 1. Most of the 
cardiovascular complications associated with hypertension are caused by alterations in 
vascular structure and function. Indeed, hypertension is associated with endothelial 
dysfunction and increased arterial stiffness 2-4. Both endothelial dysfunction 5 and arterial 
stiffness 4 are increasingly being recognized as independent cardiovascular risk factors.  
Oxidative stress, defined as an excessive amount of oxidative substances, relative to 
endogenous antioxidant capacity, has shown to be increased in conditions such as 
hypertension, resulting in a reduced NO-availability in these subjects 6, 7. It is hypothesized 
that antioxidants provide vascular defense against oxidative stress by reducing free radicals 
and protecting NO from inactivation, therefore exerting its’ beneficial effects on vascular 
function and structure. 
Data already indicate that acute oral administration of vitamin C (2 g) can have beneficial 
effects on arterial stiffness measured as augmentation index in healthy subjects 8. In 
hypertensive patients, intra-arterial administration of vitamin C has shown to improve 
endothelium-dependent vasodilation in the forearm microcirculation of hypertensive patients, 
primarily by restoring NO-availability 6. However, it was shown that this beneficial effect in 
hypertensive patients was only seen at supra-physiological doses of ascorbic acid 6, 9. Indeed, 
available results demonstrate that prolonged oral administration of ascorbic acid at 500 
mg/day for one month did not improve endothelial function in essential hypertensive patients 
10
. Moreover, administration with vitamin E as the sole antioxidant did not improve arterial 
endothelial function in older adults 11. 
Different studies assessing the effect of antioxidant supplementation have combined vitamin 
C with vitamin E, a lipid soluble vitamin with a protective effect on lipid peroxidation 12, 13. 
This combination is of special interest, since it is known that vitamin E can have pro-oxidant 
properties and appropriate concentrations of vitamin C are necessary for the regeneration of 
vitamin E 14. Because of synergism between vitamin C and E, it is conceivable that combined 
supplementation with both vitamins exerts a major antioxidant effect.   
At the present time no data is available on the possible effects of combined vitamin C and E 
on arterial stiffness and endothelial function in a population of untreated hypertensive 
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patients. Therefore, the aim of this study was to evaluate the effect of short-term combined 
antioxidant treatment with vitamin C and E on these vascular parameters and oxidative stress 
in untreated essential hypertensive patients. 
Methods 
Study population 
The study included 30 never treated, male, essential hypertensive patients (mean age 50 years; 
range 42-60 years). Patients were recruited among newly diagnosed cases in our outpatient 
clinic. Inclusion criteria were age between 40 and 60 years, sitting clinical blood pressure 
(after 10 minutes of rest) values between 140-90 and 160-99 mmHg, confirmed in two 
separate occasions within one month and presence of target organ damage according to ESH-
ESC guidelines 1. Exclusion criteria were history of cardiovascular disease, diabetes mellitus, 
dyslipidemia, BMI more than 30 kg/m2, alcohol consumption (> 50 g/ day), smoking, 
currently performing vigorous physical exercise or using mineral or vitamin supplements, 
antihypertensive drugs or statins.  
Study design 
According to a randomized, double blind, placebo-controlled, crossover study design, patients 
received combined vitamin C (1g) and vitamin E (400 IU) or placebo, once a day, for 8 
weeks. After a wash-out period of four weeks, patients were assigned to the inverse treatment 
(fig. 1). At baseline, after 8 weeks and at the end of the study, vascular studies were 
performed twice, on two consecutive days. In between, subjects underwent 24-hour blood 
pressure monitoring (ABPM) to control for blood pressure changes. Blood samples were 
collected for the determination of lipid and glucose profile, plasma markers of oxidative stress 
and antioxidant status. Patients were asked not to change physical activity habits and dietary 
intake during the study. Dietary intake of foods and nutrients was assessed at baseline, after 8-
weeks and at the end of the study by a 3-day food record. Physical activity levels were 
assessed and controlled with a modified Baecke questionnaire 15. The investigation conformed 
with the principles outlined in the Declaration of Helsinki 16. All study participants gave 
written informed consent for the study. 
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Figure 1 - Outline of study design. * Vascular studies, ABPM monitoring, blood samples for 
plasma markers of oxidative stress and antioxidant status were performed. 
Essential hypertensive 
patients (n=30)
Randomization
Vitamin C (1g) and 
Vitamin E (400 UI)
Wash-out + cross-over
Placebo
Placebo Vitamin C (1g) and 
Vitamin E (400 UI)
4 weeks
8 weeks
4 weeks
8 weeks
*
*
*
 
Vascular function 
After an overnight fast, measurements were performed with the subjects in supine position in 
a quiet, air-conditioned room (22-24°C). Radial tonometry was performed by one trained 
operator (Y.P.). Blood pressure was calculated as the mean value of three measurements made 
at 3 minutes interval by automatic device at the dominant arm (OMRON-950 CP) to calibrate 
the measurements. A hand held probe was placed on the right radial artery from the wrist of 
the dominant arm and 10-15 subsequent images were recorded. Pulse Wave Analysis (PWA) 
(SphygmoCor, AtCor Medical, Sydney, Australia) was used to transform the radial pressure 
waveform into the aortic pressure waveform by using a validated transfer function 17. Three 
successive measurements were recorded. Augmented pressure (AP) was calculated as the 
difference between the first systolic peak and the second systolic peak and augmentation 
index (AIx) was calculated as the ratio between AP and pulse pressure (PP). Since AIx in this 
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study correlated with heart rate, values were normalized at a heart rate of 75 beats/min. 
Central pulse wave velocity (CPWV) was assessed with the same device, recording 
waveforms at the femoral and carotid site sequentially. Surface distance between the two 
recording sites was measured. A simultaneously recorded ECG was used as a reference frame 
to calculate wave transit time. An intra-observer reproducibility study in our lab showed a 
coefficient of variation of 14% for AIx and 13% for CPWV. 
Endothelium-dependent response was assessed as dilation of the brachial artery to increased 
flow (flow mediated dilation, FMD), as previously described 18. Briefly, a B-mode scan of the 
right brachial artery was obtained in longitudinal section between 5 cm and 10 cm above the 
elbow using a 7.5 MHz linear array transducer, held by a stereotactic clamp to ensure a 
constant image. B-mode images were triggered to the ECG signal to obtain only end-diastolic 
frames. Arterial flow velocity was obtained by pulsed Doppler signal at 70° to the vessel with 
the range gate (1.5 mm) in the center of the artery. A cuff was placed around the forearm just 
below the elbow and was inflated for five minutes at 250 mmHg and then deflated to induce 
reactive hyperemia. Endothelium-independent dilation was obtained by administration of a 
low dose (25 µg) of sublingual glyceril trinitrate (GTN).  
Brachial artery diameter (BAD) measurements were performed after studying the acquired 
frames by the computerized edge detection system 19. Baseline vessel size was considered as 
the mean of measures obtained during the first minute. FMD and response to GTN were 
calculated as the maximal percent increase in diameter above baseline. Doppler flow velocity 
was measured at baseline and within 15 seconds after cuff release. Volume blood flow was 
calculated by multiplying Doppler flow velocity (corrected for the angle) by heart rate and 
vessel cross-sectional area (pir2). Reactive hyperemia (RH) was the maximum percent increase 
in flow after cuff release as compared to baseline flow.  
Blood sampling and biochemical measurements 
Venous blood was collected in lithium-heparin or EDTA tubes and immediately placed on 
ice.  Plasma was immediately centrifuged and stored at –70°C until assayed. Total serum 
cholesterol, triglycerides, HDL-cholesterol and plasma glucose were assessed by enzymatic 
methods (Roche, Diagnostic, Mannheim, Germany). LDL-cholesterol was calculated with 
Friedewalds’ equation. Oxidative stress was evaluated through measurement of plasma 
malondialdehyde (MDA) by spectrophotometric assay 20 and plasma lipoperoxides (LOOH) 
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with a colorimetric method, as previously described 18. Antioxidant capacity was measured as 
plasma total antioxidant capability by measuring ferric-reducing antioxidant power (FRAP; 
spectrophotometric assay)21.  
For the detection of Vitamin C, tubes were incubated for 10 minutes at 2-8° C and then 
centrifuged at 10.000 rpm for 10 minutes. For Vitamin E, blood samples were centrifuged for 
5 minutes at 2000 rpm. Then plasma was stored at –20° C and protected from light until 
analyzed. High performance liquid chromatography (HPLC) was used to determine plasma 
vitamin C (HPLC-Analytik, Immundiagnostik AG, Bensheim, Germany) and vitamin E 
(Chromsystems, Instruments & Chemicals GmbH, Munchen, Germany)22.   
Statistical analysis. 
Data are expressed as means ± SD, unless otherwise stated and were analyzed as change from 
baseline by using Student’s t-tests for paired data or non-parametric test if necessary. 
Differences were considered statistically significant when p < 0.05. Univariate and 
multivariate analysis were used to examine associations between variables. All statistical 
procedures were performed using the Statview program (Abacus Concepts, Inc., SAS 
Institute, Cary, NC). Vascular responses (AIx, CPVW, FMD, response to GTN) were 
calculated as the mean value of the measures obtained in the two following days. 
Results 
During the study, dietary and physical activity habits and body weight were not modified. 
Clinical characteristics were similar at each phase of the study (table 1). 
ABPM values were not significantly changed during the study as well as central blood 
pressure levels measured by PWA. After antioxidant supplementation, FMD significantly 
(p<0.001) improved as compared to placebo, while response to GTN was not modified (fig. 
2). 
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Table 1- Clinical characteristics of study population 
Variable Baseline Vitamin C and E Placebo 
BMI (kg/m2) 
24 h-SBP (mmHg)  
24 h-DBP (mmHg) 
Total cholesterol (mmol/L) 
HDL cholesterol (mmol/L) 
LDL cholesterol (mmol/L) 
Triglycerides (mmol/L) 
Plasma glucose (mmol/L) 
Hematocrit (%) 
Hemoglobin (g/L) 
Central SBP (mmHg) 
Central DBP (mmHg) 
27.2±2.2 
135±10 
87±7 
5.38±0.96 
1.27±0.37 
3.38±0.96 
1.53±0.6 
5.39±0.5 
42.3±4.8 
159±12 
139±13 
90±5 
27.1±2.3 
134±10 
86±7 
5.47±0.93 
1.31±0.31 
3.48±0.96 
1.56±0.7 
5.41±0.6 
43.6±3.5 
157±10 
139±15 
89±7 
27.3±2.3 
134±10 
87±6 
5.34±0.98 
1.26±0.37 
3.42±0.95 
1.53±0.6 
5.37±0.5 
44.6±3.5 
156±13 
138±13 
89±7 
BMI = body mass index; 24 h- = 24 hours ambulatory; SBP = systolic blood pressure; 
DBP = diastolic blood pressure; HDL= high-density lipoprotein; LDL= low-density lipoprotein. 
 
Figure 2 - Differences in flow mediated dilation (FMD) and response to sublingual glyceril 
trinitrate (GTN) at baseline (white bars), after 8-week vitamin antioxidant supplementation 
(black bars) as compared to placebo (gray bars). * Denotes a significant difference (p<0.001) 
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After antioxidant supplementation, the outgoing pressure wave (P1) increased, but not 
significantly (from 33.5 to 34.3 mmHg; p=ns), time to first systolic peak (T1) was not 
modified, whereas time to the second systolic peak (T2) increased significantly (from 234 to 
241 ms; p<0.01). AIx was reduced, although not significantly (p=0.09), while CPWV was 
significantly (p<0.01) lowered after antioxidant supplementation (fig. 3). 
Figure 3 - Differences in augmentation index (AIx) and central pulse wave velocity (CPVW) at 
baseline (white bars), after 8-week vitamin antioxidant supplementation (black bars) as 
compared to placebo (gray bars). * Denotes a significant difference (p<0.01) 
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Changes in markers of oxidative stress and antioxidant status are reported in table 2. 
Compared to the placebo group, plasma vitamin C, E and FRAP levels increased 
significantly. After antioxidant supplementation, plasma levels of MDA decreased, although 
not significantly, while levels of LOOH were significantly reduced as compared to placebo. 
The increase in levels of vitamin C was significantly related with the changes in FRAP and 
LOOH (R=0.37; p<0.05, R=-0.40, p<0.05, respectively). Changes in FRAP were related with 
changes in MDA (R=-0.37, p<0.05). 
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Table 2- Markers of oxidative stress and antioxidant status 
Variable Baseline Vitamin C and E Placebo 
MDA (µmol/l) 
LOOH (µmol/l) 
FRAP (µmol/l) 
Plasma Vitamin C (µmol/l) 
Plasma Vitamin E (µmol/l) 
2.33±0.84 
3.12±2.6 
789±141 
39.12±22.43 
20.41±8.68 
2.03±0.97 
2.06±1.7 * † 
831±139 † 
52.35±32.65 * † 
25.50±9.36 † 
2.35±0.92 
3.10±2.3 
783±137 
33.95±22.83 
19.81±7.55 
MDA: malondialdehyde; LOOH: lipoperoxides; FRAP: Ferric reducing ability of Plasma; * P<0.05 
vs. baseline, † P<0.05 vs. placebo. 
At baseline, FMD was related with BAD (R=-0.47; p<0.01), levels of vitamin C (R=0.40; 
p<0.05) and FRAP (R=0.36; p<0.05). AIx correlated significantly with age (R=0.50; p<0.01) 
and inversely with FRAP (R=-0.42; p<0.05). CPWV was related to SBP (R=0.40; p=0.03), 
age (R=0.38; p<0.05), LOOH (R=0.38; p<0.05) and levels of MDA (R=0.39; p<0.05). 
Multivariate analysis including also other possible confounders (age, blood pressure values, 
LDL and HDL cholesterol) showed that for FMD only BAD (p=0.02) remained a significant 
variable (R2 = 0.44). For AIx, age (p<0.01) resulted as a significant predictor (R2 = 0.32) and 
SBP (p=0.03) for CPWV (R2 = 0.40). 
Changes in FMD after antioxidant supplementation were not related with changes in CPWV 
(R=-0.14; p=n.s.). Changes in FMD showed a negative, but not significant correlation with 
changes in MDA (R=-0.31, p=0.07). Changes in CPWV after antioxidant supplementation, 
were related with changes in levels of MDA (R=0.43; p<0.05) and borderline with changes in 
levels of FRAP (R=-0.30, p=0.06). The changes in AIx were significantly related with the 
observed differences in levels of MDA (R=0.41; p<0.05). When multivariate analysis was 
performed including possible confounding variables including age, blood pressure values, 
LDL and HDL cholesterol, changes in MDA remained significantly related with changes in 
CPWV (R2=0.31) and AIx (R2= 0.29). 
Discussion 
The present study demonstrates that oral supplementation with vitamin C and E for 8 weeks 
improves arterial stiffness and endothelial function in untreated essential hypertensive 
patients. Supplementation with vitamins increased total plasma antioxidant capacity, vitamin 
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C and vitamin E levels and reduced the plasma oxidative markers LOOH and MDA, 
indicating a beneficial modulation of systemic markers of oxidative stress. 
To our knowledge no previous study has investigated the effect of antioxidant vitamins on 
both arterial stiffness and endothelial function in essential hypertensive patients. Concerning 
arterial stiffness data are not consistent, showing either a beneficial 8, 23 or no effect 24 of 
different kinds of antioxidant supplementation on parameters of arterial stiffness in apparently 
healthy subjects. However, an improvement in central aortic AIx was shown after 500 mg/day 
oral vitamin C supplementation for one month in a population of type II diabetes 25.  
In the present study, oral supplementation with combined vitamins significantly improved in 
CPWV. Importantly, the improvement in CPWV in the present study was related with a 
decreased level of oxidative stress markers. Furthermore, AIx, an integrated index of arterial 
stiffness and arterial wave reflection, was lowered after antioxidant supplementation, but not 
significantly. Since central blood pressure levels remained unchanged, the change in AIx can 
be most likely explained by the observed increase of the outgoing pressure wave (P1). A 
significant increase in T2 was also observed. Thus, supplementation with antioxidants seems 
to have a greater beneficial effect on central large artery function as demonstrated with the 
results obtained with CPWV. These results suggest that oxidative stress plays a role in 
determining arterial stiffness in untreated hypertensive patients.  Since an 8-week treatment is 
not sufficient to induce any significant change in vascular structure, it is conceivable that 
functional mechanisms account for the improvement in arterial stiffness, such as an 
improvement in endothelial function 26 and a possible beneficial effect of antioxidants on 
protein cross-linking in conduit arteries, including the aorta 27.  
FMD improved after antioxidant supplementation, while no significant changes were 
observed in the response to GTN. These results indicate that treatment with combined 
vitamins selectively improves endothelium-dependent vasodilation of the brachial artery. The 
improvement in FMD was not significantly related to changes in antioxidant status or 
oxidative stress after vitamin supplementation. However, it was already suggested that 
evaluation of plasma markers of oxidative stress may not accurately reflect oxidative status at 
the level of endothelial cells 18. Previous studies have shown that the beneficial effect of 
ascorbic acid administration on endothelial function in hypertensive patients was only 
achieved at supra-physiological doses by intra-arterial administration 6, 9, while prolonged oral 
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administration (500 mg/day for one month) was not effective 10. On the contrary, a beneficial 
effect of a similar treatment with ascorbic acid has been described in patients with CAD 28. 
Finally, in apparently healthy older subjects, 10 weeks daily supplementation with vitamin E 
(1000 IU/day) failed to show a beneficial effect on endothelial function 11. 
It is conceivable that the beneficial effect of the chronic oral antioxidant treatment on 
endothelial function, at least in patients at relatively low cardiovascular risk such as our 
population of untreated hypertensive patients, requires the administration of combined 
Vitamin C and Vitamin E at appropriate dosages. Indeed, vitamin C can reverse the pro-
oxidant status of Vitamin E in turning α-tocopheroxyl back into α-tocopherol 14. Thus, 
combined treatment can more effectively counteract on the NO scavenging action of oxidative 
stress and can also increase NO production persé 29. In fact, ascorbic acid can improve 
tetrahydrobiopterin availability in the vasculature and α-tocopherol exerts a direct stimulatory 
effect on e-NOS activation, an effect which is amplified by ascorbic acid, suggesting that both 
compounds may act synergistically in optimizing endothelial NO synthesis 29. 
Our results may have clinical implications since both endothelial dysfunction and arterial 
stiffness are early mechanisms of vascular alterations and independent predictors of 
cardiovascular diseases 4, 5. The major part of controlled studies evaluating the effect of 
vitamin supplementation on vascular lesions and cardiovascular events, show inconclusive 
results 30-33. One of the possible explanations could reside in the clinical conditions of the 
study populations in which the presence of advanced vascular alterations or associated clinical 
conditions might influence negatively on the beneficial effect of antioxidant vitamins. An 
alternate explanation could be the long term use of vitamin E (α tocopherol) as the sole 
antioxidant supplement in some of the studies 11, 31, 32, 34. Thus our results may suggest that an 
early combined treatment with vitamin C and E in uncomplicated essential hypertensive 
patients can have beneficial effects in the prevention of vascular alterations and 
cardiovascular events. 
In our study clinic, ambulatory and central blood pressure levels were not changed by 
antioxidant vitamin supplementation. Although one study suggested that treatment with oral 
vitamin C (500 mg/day, 30 days) was associated with a reduction in blood pressure values 35, 
a recent review revealed that no real evidence exists for an effect of antioxidant 
supplementation in preventing or treating high blood pressure 36. 
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One possible limitation of the present study is the fact that no measurements of intravascular 
oxidative stress were performed. Therefore, our conclusions on the associations between 
differences in oxidative stress and vascular parameters can be over- or under estimated. 
Furthermore, the results of the present study do not permit to draw conclusions on an in vivo 
interaction of the combined supplementation, since the effects of Vitamin C or E alone were 
not evaluated. 
In conclusion, this randomized study demonstrated that as compared to placebo combined 
oral antioxidant treatment with vitamin C and E for 8 weeks has beneficial effects on arterial 
stiffness and endothelial function in untreated essential hypertensive patients. The 
improvements in arterial stiffness and possibly in endothelial function seem to be due to an 
effective increase in antioxidant defenses leading to a subsequent decrease in oxidative stress. 
Further research is still needed to study the potential long-term benefit of vitamin antioxidant 
supplementation on prevention of early vascular alterations. 
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Chapter 7 
RELATIONSHIP BETWEEN MEASUREMENTS OF 
PULSE WAVE ANALYSIS, PULSE WAVE VELOCITY 
AND FLOW MEDIATED DILATION IN 
NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 
(preliminary results) 
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Introduction 
Endothelial dysfunction 1 and increased arterial stiffness 2 are increasingly being recognized 
as powerful predictors of cardiovascular disease morbidity and mortality. Both conditions 
have shown to occur simultaneously in populations at high risk for cardiovascular disease 
such as patients with hypercholesterolemia, hypertension and diabetes. 
The endothelium has important properties in controlling both vascular tone and vascular 
structure by the production of multiple relaxing factors such as nitric oxide, prostacyclin and a 
not yet identified hyperpolarizing relaxing factor (EDHF) 3. Furthermore, endothelial 
dysfunction is an early, functional and potentially reversible alteration of endothelial cells, 
resulting from an impairment in NO availability 4 and can be detected by flow mediated 
dilation of the brachial artery 5. 
Arterial stiffening, a result of structural and functional alterations of the vascular wall can be 
measured by means of pulse wave velocity (PWV) and pulse wave analysis (PWA) 6. Lately, 
it has been suggested that nitric oxide may play a role in regulating arterial stiffness 7. Studies 
have shown that substances associated with increase in NO production, including glyceryl 
trinitrate (GTN), reduce arterial stiffness and wave augmentation, whereas inhibitors of NO, 
such as L-NMMA, increase indexes of arterial stiffness 7. Since endothelial dysfunction and 
arterial stiffness both play a role in the atherosclerotic process, studies have already suggested 
that measurements of endothelial function and arterial stiffness are correlated. These studies 
however are not conclusive and are conducted in different populations. The aim of this study 
was to evaluate the possible relationship between endothelial function measured as flow 
mediated dilation (FMD) of the brachial artery and arterial stiffness assessed with PWA and 
PWV in a large population of untreated essential hypertensive patients and normotensive 
controls. 
Methods 
Study population 
In this cross-sectional study, 242 (79 females) hypertensive patients (HT) between 20 and 70 
years of age were recruited for the study from February 2004 to December 2005. To serve as 
control, 192 normotensive subjects (NT) (64 females) were added. Patients with essential 
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hypertension were recruited from the newly diagnosed cases in our outpatient clinic and were 
enrolled if sitting clinic arterial blood pressure (after 10 minutes of rest) was consistently 
found to be greater than 140/90 mmHg, confirmed in two separate occasions within one 
month according to European guidelines 8. Patients had never been treated (n=172) or had a 
history of recent or discontinuous treatment (n=70), with a pharmacological washout for at 
least 3 weeks before entering the study. Subjects with medical history of cardiovascular 
events, cardiovascular diseases or other diseases requiring medical treatment, were excluded 
for the study. Subjects were defined as normal according to the absence of familial history of 
essential hypertension and blood pressure values below 140/90 mmHg. 
FMD, augmentation index (AIx) and radial-carotid pulse wave velocity (BPWV) were 
measured in all subjects. Carotid femoral pulse wave velocity (CFPWV) was assessed in a 
subgroup of 112 subjects (HT=66; NT=46). Body weight and height were measured in all 
subjects. Body mass index (BMI) was calculated as weight/height2. Blood samples were 
collected following an overnight fast to measure lipid and glucose profile. Information on 
current smoking status (smoker/non smoker) was also collected. The study complied with the 
declaration of Helsinki of the World Medical Association and the local ethical committee 
approved the protocol. All study participants gave written informed consent for the study. 
Vascular function 
After an overnight fast, measurements were performed with the subjects in supine position in 
a quiet, air-conditioned room (22-24°C). Radial tonometry was performed by one trained 
operator (Y.P.). Blood pressure was calculated as the mean value of three measurements made 
at 3 minutes interval by automatic device at the dominant arm (OMRON-950 CP) to calibrate 
the measurements. A hand held probe was placed on the right radial artery from the wrist of 
the dominant arm and 10-15 subsequent images were recorded. PWA (SphygmoCor, AtCor 
Medical, Sydney, Australia) was used to transform the radial pressure waveform into the 
aortic pressure waveform by using a validated transfer function 9. Three successive 
measurements were recorded. Augmented pressure (AP) was calculated as the difference 
between the second systolic peak and first systolic peak and AIx was calculated as the ratio 
between AP and pulse pressure (PP). Since AIx in this study correlated with heart rate, values 
were normalized at a heart rate of 75 beats/min.  
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CFPWV was assessed with the same device, recording waveforms at the femoral and carotid 
site sequentially. BPWV was assessed recording waveforms at the radial and carotid site. 
Surface distance between the two recording sites was measured. A simultaneously recorded 
ECG was used as a reference frame to calculate wave transit time. An intra-observer 
reproducibility study in our lab showed a coefficient of variation of 14% for AIx and 13% for 
CFPWV and BPWV. 
Endothelium-dependent response was assessed as dilation of the brachial artery to increased 
flow (FMD), as previously described 10. Briefly, a B-mode scan of the right brachial artery 
was obtained in longitudinal section between 5 cm and 10 cm above the elbow using a 7.5 
MHz linear array transducer, held by a stereotactic clamp to ensure a constant image. B-mode 
images were triggered to the ECG signal to obtain only end-diastolic frames. Arterial flow 
velocity was obtained by pulsed Doppler signal at 70° to the vessel with the range gate (1.5 
mm) in the center of the artery. A cuff was placed around the forearm just below the elbow 
and was inflated for five minutes at 250 mmHg and then deflated to induce reactive 
hyperemia. Endothelium-independent dilation was obtained by administration of a low dose 
(25 µg) of sublingual glyceril trinitrate (GTN).  
Brachial artery diameter measurements were performed after studying the acquired frames by 
the computerized edge detection system 11. Baseline vessel size was considered as the mean 
of measures obtained during the first minute. FMD and response to GTN were calculated as 
the maximal percent increase in diameter above baseline. Doppler flow velocity was 
measured at baseline and within 15 seconds after cuff release. Volume blood flow was 
calculated by multiplying Doppler flow velocity (corrected for the angle) by heart rate and 
vessel cross-sectional area (pir2). Reactive hyperemia (RH) was the maximum percent increase 
in flow after cuff release as compared to baseline flow.  
Statistical analysis. 
Simple regression analysis was used to examine associations between variables. Multiple 
linear regression analysis was performed in the whole study group and separately in HT 
patients and NT subjects, including in the final models all variables that in the preliminary 
regression analysis were related to the vascular parameters. Differences were considered 
statistically significant when p < 0.05. All statistical procedures were performed using the 
Statview program (Abacus Concepts, Inc., SAS Institute, Cary, NC). 
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Preliminary results 
No significant differences were found in age, gender distribution, BMI, smoking, total 
cholesterol, HDL-cholesterol or plasma glucose levels between HT and NT. HT patients 
showed significantly (p<0.0001) lower FMD (5.1±2.7) as compared with normotensive 
controls (6.0±2.7), while response to GTN was similar. AIx resulted significantly higher in 
HT (25.7±11.6) as compared to NT (19.5±12.2). CFPWV was higher in HT (8.8±1.9 m/s) as 
compared to controls (8.2±1.9 m/s) as well as BPWV ( 9.5±1.4 m/s vs. 8.7±1.1, respectively) 
and central pulse pressure (cPP) (50.1±12.6 mmHg vs. 41.3±8.4 mmHg, respectively). 
Brachial artery diameter (BAD) was significantly higher in HT as compared to NT (4.54±0.91 
vs 4.26±0.79 mm). 
In the whole group, FMD correlated with response to GTN (r=0.36, p<0.0001), cPP (r=-0.18, 
p<0.001) and BPWV (r=-0.15, p<0.01), but not with CFPWV or AIx. Multiple regression 
analysis showed that age and BAD resulted as significant predictors of FMD (R2= 0.24). 
AIx was associated with cPP (r=0.42, p<0.0001), CFPWV (r=0.31, p<0.001) and BPWV 
(r=0.22, p<0.0001), but not with response to GTN. Multiple regression analysis revealed that 
age, DBP, height, BAD, CFPWV and SBP resulted as significant predictors of AIx (R2=0.64). 
Leaving CFPWV out of the model, because of lower number of subjects, age, diastolic blood 
pressure (DBP), BAD, height and BPWV become determinants of AIx (R2=0.57). 
In the whole group, BPWV was associated with FMD, AIx ( both see above), CFPWV 
(r=0.32, p<0.001) and cPP (r=0.20, p<0.0001), but not to response to GTN. Finally, DBP and 
CFPWV resulted as significant predictors (R2=0.23). Discarding CFPWV from the model, 
DBP and BAD emerge as predictors of BPWV (R2=0.20). 
CFPWV showed associations with cPP (r=0.21, p=0.03), BPWV, AIx, but not with FMD (see 
above) or response to GTN. Multiple regression analysis showed that systolic blood pressure 
(SBP), DBP, AIx, BPWV, BAD and cPP resulted as significant determinants of CFPWV 
(R2=0.37). 
In the HT group, FMD correlated with response to GTN (r=0.33, p<0.0001), BPWV (r=-0.20, 
p<0.01) and cPP (r=-0.14, p=0.04), but not with CFPWV or AIx. Multiple regression analysis 
showed that BAD, age, response to GTN and BPWV resulted as significant predictors of 
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FMD (R2= 0.29). AIx was associated with cPP (r=0.38, p<0.0001), CFPWV (r=0.24, p=0.05) 
and borderline with BPWV (r=0.21, p=0.08), but not with response to GTN. Multiple 
regression analysis revealed that age, BAD, DBP, height and CFPWV resulted as significant 
predictors of AIx (R2=0.54). Discarding CFPWV from the model, age, height, BAD, DBP, 
SBP and BMI become significant determinants of AIx (R2=0.48). 
BPWV was associated with FMD and borderline with AIx (see above), but not with CFPWV, 
cPP or response to GTN. Finally, DBP and FMD resulted as significant predictors of BPWV 
(R2=0.16). CFPWV showed associations with cPP (r=0.25, p=0.05) and AIx (see above), but 
not with FMD or response to GTN. AIX and BAD resulted as significant determinants of 
CFPWV (R2=0.19). 
In the normotensive group, FMD correlated with response to GTN (r=0.39, p<0.0001), but not 
with BPWV, CFPWV or AIx. Multiple regression analysis showed that response to GTN, 
BAD and age resulted as significant predictors of FMD (R2= 0.26). 
AIx was associated with cPP (r=0.38, p<0.0001), CFPWV (r=0.35, p=0.02) and BPWV 
(r=0.20, p<0.01), but not with response to GTN. Multiple regression analysis revealed that 
age, height and DBP resulted as significant predictors of AIx (R2=0.63). Leaving CFPWV out 
of the model showed that age, DBP, BAD and height result as determinants of AIx (R2=0.60). 
BPWV was associated with AIx (see above) and CFPWV (r=0.54, p<0.0001), but not with 
FMD or response to GTN. Finally, CFPWV resulted as significant predictor of BPWV 
(R2=0.34). Without CFPWV added in the regression model, only DBP resulted as significant 
predictor of BPWV (R2=0.11). Finally, CFPWV showed associations with BPWV and AIx 
(see above), but not with FMD or response to GTN. Finally, SBP and BPWV resulted as 
significant determinants of CFPWV (R2=0.52). 
Discussion 
Our results reveal that brachial artery endothelial function, measured as FMD and the 
measurements of augmentation index and CFPWV are not associated in our population of 
hypertensive patients and normotensive subjects. The lack of a significant relationship 
between conduit artery endothelial function and central arterial stiffness and wave reflection 
suggests that these parameters are different entities of structure and function of the vascular 
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tree. However, BPWV, a marker of peripheral arterial stiffness, and FMD were related in the 
essential hypertensive patients. This could confirm data from studies, which showed that the 
measurement of FMD of the brachial artery was affected by local elastic properties in high-
risk patients or the elderly 12. It was hypothesized that a stiff artery, with preserved NO 
availability, cannot reach the maximal dilation due to physical restrictions 13. This could 
highly influence the validity of FMD measurements especially in high-risk patients. 
However, in cardiovascular risk assessment both endothelial function and arterial stiffness 
both play a role in the atherosclerotic process. Both parameters have shown their value in 
predicting cardiovascular disease 1, 2 and even so important they have shown to be modifiable 
factors. Therefore in the risk assessment and in studies evaluating vascular function and 
structure it is suggested to measure both endothelial function and arterial stiffness in order to 
have a complete and proper view of the vascular tree and to prevent possible validity 
problems. 
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Figure 1 - Correlation between FMD and AIx in hypertensive patients and normotensive 
subjects 
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Figure 2 - Correlation between FMD and BPWV in hypertensive patients and normotensive 
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In the prevention and reduction of cardiovascular disease, different modifiable cardiovascular 
risk factors have already been identified. Hypertension is one of the major important 
modifiable risk factors for cardiovascular disease1. The stratification of risk in hypertensive 
patients is related to blood pressure values, other cardiovascular risk factors such as 
unfavorable lipid profile, obesity, diabetes mellitus, target organ damage and associated 
clinical conditions2. Patients with essential hypertension are characterized by early alterations 
in vascular structure and function, such as endothelial dysfunction3, 4 and increased arterial 
stiffness5 and wave reflection6 and these alterations are increasingly being recognized as 
independent cardiovascular risk factors 5, 7. Hypertension is not only a major cardiovascular 
risk factor but is also likely to be accompanied by other CV risk factors such as unfavorable 
lipid profile, insulin resistance, obesity and diabetes mellitus 2. 
The metabolic syndrome represents the association of high blood pressure, increased 
abdominal obesity, dyslipidemia and altered glucose tolerance 8 and is accompanied by an 
increase in CV disease in the general population, but also in essential hypertensive patients9. 
It has been suggested that the presence of the metabolic syndrome exerts a deleterious effect 
on vascular alterations, especially in subjects with hypertension 10-12. However, in chapter 2 
we showed that in our population of untreated hypertensive patients, the presence of the 
metabolic syndrome does not account for a ulterior increase in endothelial dysfunction or 
augmentation index other than that caused by the high levels of blood pressure. These results 
support the hypothesis that blood pressure is the most important component of the metabolic 
syndrome in defining conduit artery endothelial function and augmentation index, an 
integrated index of arterial stiffness and peripheral wave reflection, in these subjects. The lack 
of influence of the metabolic syndrome on the vascular parameters could be explained by the 
presence of overt disease such as untreated hypertension. In our population of untreated 
hypertensive patients, the incremental risk attributable, for example, to raised triglycerides or 
low HDL-cholesterol, is likely to be overwhelmed by the presence of hypertension. 
Furthermore, we don’t know if in our population central arterial stiffness was affected since 
we only measured augmentation index as an index of arterial stiffness. Indeed, previous 
studies indicated that the metabolic syndrome can increase central arterial stiffness, measured 
as carotid-femoral PWV10, 11. Another explanation could reside in the fact that we used the 
ATP III criteria 8, which does not take insulin resistance into account as a factor of the 
metabolic syndrome. 
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A wide range of interventions are evaluated to prevent of modify the above mentioned 
vascular functional and structural alterations. We however focused our attention on the 
possible effect of lifestyle habits on these parameters. In all the research available on life style 
modifications and cardiovascular disease, it is already clear that being physically active exerts 
a beneficial effect on cardiovascular risk factors. It has been shown that regular physical 
activity lowers blood pressure, which results in a decrease in CHD, stroke and total mortality 
13
. It has been hypothesized that the reduction in CV events could be related to the parallel 
improvement in vascular parameters. The beneficial effect of physical activity has been 
shown in the attenuation of the age related increase in endothelial dysfunction 14 and different 
studies have shown an improvement of endothelial function with physical activity 
interventions 15. Furthermore physical activity has shown to exert beneficial effects on arterial 
stiffness, since both pulse wave velocity and augmentation index have shown to be reduced 
by physical exercise 16-19. However, no data was available on the effect of regular habitual 
physical activity on arterial wave reflection. 
Therefore, in chapter 3 we showed that regular physical activity was associated with a lower 
augmentation index in normotensive subjects, but this association was less clear in untreated 
hypertensive patients. The most likely explanation for these findings is that the moderate 
physical activity exerted in our population was not sufficient to show a similar effect on wave 
reflection in patients with or without hypertension. Since hypertension increases arterial 
stiffness and arterial wave reflection, it is conceivable that the degree of physical activity was 
less effective to counterbalance the increase in augmentation index in hypertensive patients. 
These results could suggest that higher levels of physical activity are required to modify 
arterial wave reflection in untreated hypertensive patients, at least when hypertension is not 
yet treated with pharmacological interventions to normalize blood pressure levels. 
On the other hand, in chapter 4 we showed that the age-related decrease in endothelial 
function measured as FMD is attenuated in elderly athletes, who performed endurance 
exercise for longer periods, as compared to sedentary peers. In sedentary individuals, 
increasing age was associated with a decrease in endothelial function measured as FMD, with 
a parallel attenuation of plasma antioxidant capacity and increased markers of oxidative 
stress. However, the decrease in FMD in elderly subjects who performed aerobic endurance 
exercise was attenuated. Moreover this effect was associated with higher plasma antioxidant 
capacity.  
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Therefore, the mechanism responsible for the beneficial effect of physical activity on vascular 
function could in part be due to an increased antioxidant defense capacity. Cardiovascular risk 
factors such as hypertension, but also (sedentary) aging are accompanied by oxidative stress, 
defined as an excessive amount of oxidative substances, relative to endogenous antioxidant 
capacity, resulting in a reduced NO-availability 20, 21. Therefore, an increase in antioxidant 
capacity could counteract on the deleterious effect of oxidative stress on the vascular tree. 
Regarding the possible effects of antioxidants, studies have been done on the effect of 
antioxidant vitamins, in regular foods or as food supplements and the risk of cardiovascular 
disease. The apparent beneficial results of high intake of antioxidant vitamins in observational 
studies are not conclusive. We hypothesized that high dietary intake of vitamin 
supplementation or experimental oral supplementation with antioxidants could have 
beneficial effects on cardiovascular disease especially in patients with essential hypertension. 
However, in chapter 5 we showed that the intake of vitamin antioxidant C and E through 
regular food was not related with augmentation index or endothelial function in both 
hypertensive patients and normotensive subjects. These results suggest that the relatively low 
intake of vitamin C and E in regular food is not sufficient to have an effect on conduit artery 
endothelial function or arterial wave reflection. 
Indeed, in chapter 6 we were able to demonstrate that in a subgroup of patients with 
untreated essential hypertension, short term supplementation with combined higher doses of 
the antioxidant vitamins C and E had beneficial effects on both endothelial function and 
arterial stiffness. Interestingly, these improvements were parallel with an increase in total 
plasma antioxidant capacity, vitamin C and vitamin E levels and a reduction in the plasma 
oxidative markers, indicating a beneficial modulation of systemic markers of oxidative stress. 
These results confirm the central role of oxidative stress in inducing endothelial dysfunction 
and increased arterial stiffness, at least in patients with essential hypertension, and the 
necessity to use adequate doses and combination of antioxidants to obtain beneficial effects. 
Finally, since both endothelial function and arterial stiffness improved with antioxidant 
supplementation and both conditions play a role in the atherosclerotic process, it can be 
suggested that measurements of endothelial function and arterial stiffness are correlated. 
However, our results obtained in both hypertensive and normotensive subjects, described in 
chapter 7, suggest that the measurements of FMD, PWA and PWV assess different entities of 
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structure and function of the vascular tree. Therefore in the risk assessment and in studies 
evaluating vascular function we recommend to measure both endothelial function and arterial 
stiffness in order to have a complete and proper view of the vascular tree. 
Conclusions 
It is well established that essential hypertension is a powerful predictor of cardiovascular 
disease, accompanied by endothelial dysfunction and increased arterial stiffness and 
peripheral wave reflection. The presence of the metabolic syndrome in our patients with overt 
disease such as hypertension does not seem to be associated with ulterior increase in 
endothelial dysfunction or arterial stiffness. In our population, regular physical activity was 
associated with a lower augmentation index in normotensive subject and to a far lesser extent 
in hypertensive patients. Furthermore we found an association between regular high intensity 
endurance exercise, antioxidant capacity and preserved endothelial function in healthy older 
men, confirming the important mechanism of antioxidant defenses against oxidative stress. In 
this line we also showed a beneficial effect of short term, high dose combined antioxidant 
supplementation on arterial stiffness and endothelial function in a small group of untreated 
essential hypertensive patients, while this association with the vascular parameters was not 
observed when evaluating the effects of regular dietary antioxidant intake in the whole 
population. Finally, we revealed that the measurements of FMD, PWA and PWV assess 
different entities of structure and function of the vascular tree and it is recommended to 
measure both vascular parameters in future research. 
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L’ipertensione essenziale è caratterizzata da alterazioni vascolari precoci come la disfunzione 
endoteliale e l’aumento della rigidità arteriosa e della riflessione dell’onda sfigmica. Tali 
alterazioni sono considerate predittori indipendenti dello sviluppo di eventi cardiovascolari. 
Poichè l’associazione di fattori di rischio multipli, come nella sindrome metabolica, si associa 
ad un aumentato rischio di morbidità e mortalità cardiovascolare nei pazienti con ipertensione 
arteriosa, il primo scopo di questa tesi è stato quello di valutare l’effetto della presenza della 
sindrome metabolica sulla disfunzione endoteliale,  la rigidità arteriosa e la riflessione 
dell’onda sfigmica in un gruppo di pazienti ipertesi essenziali. 
L’attività fisica e la dieta sono le più importanti misure non farmacologiche per la 
prevenzione del rischio cardiovascolare. Tali misure possono avere effetti favorevoli sia sulla  
disfunzione endoteliale,  che sulla rigidità arteriosa e la riflessione dell’onda sfigmica. 
Pertanto il secondo scopo della tesi è stato quello di valutare l’effetto dell’attività fisica, 
dell’apporto dietetico e della supplementazione di vitamine antiossidanti su tali parametri 
vascolari nei pazienti ipertesi essenziali. 
Sono state utilizzate valutazioni trasversali ed uno studio randomizzato di intervento verso 
placebo, in doppio cieco con disegno di crossover. La risposta endotelio-dipendente è stata 
valutata come vasodilatazione mediata da incremento di flusso (flow mediated dilation) 
dell’arteria omerale, la rigidità arteriosa come pulse wave velocity centrale ed augmentation 
index. Il livello di attività fisica e di dieta abituale è stato ottenuto con questionari validati. 
Infine, sono stati misurati alcuni parametri plasmatici di stress ossidativo e di capacità 
antiossidante. 
Nella nostra popolazione di pazienti ipertesi essenziali non trattati la presenza della sindrome 
metabolica non determinava un ulteriore peggioramento dei parametri strutturali e funzionali 
vascolari. La pressione arteriosa rappresentava il più importante componente della sindrome 
metabolica nell’influenzare la funzione endoteliale e l’augmentation index nei soggetti 
normotesi, suggerendo il ruolo primario degli elevati valori pressori nello sviluppo di queste 
alterazioni vasculari precoci. 
Il livello di attività fisica abituale si associava inversamente con i valori di augmentation 
index nei sogggetti normotesi e in maniera minore nei pazienti ipertesi. Pertanto, 
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l’ipertensione arteriosa non trattata sembrerebbe ridurre almeno parzialmente l’effetto 
benefico dell’attività fisica sulla riflessione dell’onda sfigmica. 
I soggetti anziani che avevano eseguito allenamento regolare, mostravano una migliore 
vasodilatazione endoteliale dell’arteria omerale rispetto a soggetti sedentari della stessa età. 
Tale risultato si accompagnava a livelli più elevati di capacità antiossidante plasmatica, 
suggerendo che una intensa e regolare attività fisica possa prevenire lo stress ossidativo a 
livello vascolare. 
Sebbene l’analisi trasversale della nostra popolazione non abbia mostrato alcuna relazione tra 
livelli di vitamine antiossidanti C ed E assunte abitualmente con la dieta, l’augmentation 
index e la funzione endoteliale sia negli ipertesi che nei normotesi, lo studio di intervento ha 
dimostrato che  la supplementazione combinata di vitamina C ed E è in grado di migliorare la 
vasodilatazione endotelio-dipendente e la rigidità arteriosa in un gruppo di pazienti ipertesi 
essenziali non trattati. Tale miglioramento era correlato con la riduzione dei markers 
plasmatici di stress ossidativo. I risultati di questo studio sottolineano la necessità dell’uso di 
dosi adeguate di differenti antiossidanti per ottenere un effetto benefico sui parametri 
vascolari. 
Infine, i risultati ottenuti nel gruppo di pazienti ipertesi e dei soggetti di controllo 
suggeriscono che la valutazione della funzione endoteliale nelle arterie periferiche e della 
rigidità arteriosa, sia centrale che periferica, fornisce misure differenti della funzione e della 
struttura vascolare. Pertanto nella valutazione della funzione vascolare nell’ottica di una 
migliore stratificazione del rischio cardiovascolare sarebbe auspicabile in futuro di valutare 
sia la funzione endoteliale che la rigidità arteriosa. 
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HT:  hypertensive  
NT:  normotensive 
FMD:   flow mediated dilation 
GTN:   response to sublingual nitroglycerin 
RH:   reactive hyperemia 
CFPWV:  carotid femoral pulse wave velocity 
BPWV:  brachial pulse wave velocity 
PPWV: peripheral pulse wave velocity 
AP:   augmented pressure 
AIx:   augmentation index 
CPP:   central pulse pressure 
PP:  pulse pressure 
Tr:  time to reflection 
ABPM: ambulatory blood pressure monitoring  
DBP:  diastolic blood pressure 
SBP:  systolic blood pressure 
MAP:  mean arterial pressure 
BAD:  brachial artery diameter 
CVD:  cardiovascular disease 
NO:  nitric oxide 
MS:  metabolic syndrome 
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WC:  waist circumference 
BMI:  body mass index 
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VO2 max: maximal oxygen uptake 
TOSC:  Total Oxyradical Scavenging Capacity 
MDA:  malondialdehyde 
LOOH: plasma lipoperoxides 
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